Home Cart Sign in  
Chemical Structure| 184475-35-2 Chemical Structure| 184475-35-2

Structure of Gefitinib
CAS No.: 184475-35-2

Chemical Structure| 184475-35-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gefitinib (ZD1839) acts as a potent, selective, and orally active inhibitor of EGFR tyrosine kinase.

Synonyms: ZD1839

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gefitinib

CAS No. :184475-35-2
Formula : C22H24ClFN4O3
M.W : 446.90
SMILES Code : C1=C3C(=CC(=C1OC)OCCCN2CCOCC2)C(=NC=N3)NC4=CC=C(C(=C4)Cl)F
Synonyms :
ZD1839
MDL No. :MFCD04307832
InChI Key :XGALLCVXEZPNRQ-UHFFFAOYSA-N
Pubchem ID :123631

Safety of Gefitinib

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H315-H318-H351-H360-H373-H401-H410
Precautionary Statements:P201-P202-P260-P264-P270-P273-P280-P301+P312+P330-P302+P352-P305+P351+P338+P310-P308+P313-P332+P313-P391-P405-P501
Class:9
UN#:3077
Packing Group:

Related Pathways of Gefitinib

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • EGFR/ErbB1

    Tyr992 (NR6wtEGFR cells), IC50:37 nM

    Tyr1173 (NR6W cells), IC50:57 nM

  • EGFR/ErbB1

    EGFR, IC50:15.5 nM

  • mutant EGFR

    EGFR (858R/T790M), IC50:823.3 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
HL-60 cells 10 μM 10 minutes Identify Syk as a target for AML differentiation Cancer Cell. 2009 Oct 6;16(4):281-94.
human primary hepatocytes 20 µM 24 h To investigate the effects of Gefitinib on apoptosis and autophagy, results showed that Gefitinib significantly induced apoptosis and autophagy. Autophagy. 2021 Oct;17(10):3221-3237.
HL-7702 cells 20 µM 24 h To investigate the effects of Gefitinib on apoptosis and autophagy, results showed that Gefitinib significantly induced apoptosis and autophagy. Autophagy. 2021 Oct;17(10):3221-3237.
PC-9 cells 0.01 μM 96 h To evaluate the anti-cancer effect of gefitinib in combination with Ad/ABE-TP53-EGFR, the results showed that the Ad/ABE-oncoSNP system unexpectedly elicited a significant cancer cell killing effect in PC-9 cells. Mol Ther. 2024 Oct 2;32(10):3618-3628.
H1975 cells 15 μM 96 h To evaluate the anti-cancer effect of gefitinib in combination with Ad/ABE-TP53-EGFR, the results showed that the combination treatment significantly enhanced the sensitivity to gefitinib and inhibited tumor cell proliferation. Mol Ther. 2024 Oct 2;32(10):3618-3628.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NSG mice HCC827 and ERC4 cell lines xenografts Oral gavage 20 mg/kg 17 weeks Investigate the effect of EDN1 on tumor growth and drug penetration, results showed EDN1 overexpression led to reduced tumor growth and drug penetration, while EDN1 receptor antagonist bosentan improved drug penetration and tumor response Cancer Res. 2020 Oct 1;80(19):4224-4232
C57BL/6J mice Silicosis mouse model Oral 200 mg/kg Once daily for two weeks Gefitinib and fostamatinib potently inhibited the level of p-EGFR and p-SYK respectively, and effectively alleviated silica-induced diffuse alveolitis revealed by histological examination. Meanwhile, qPCR analysis showed that the levels of pro-inflammatory cytokines (such as Interleukin-1 β (Il-1β), Interleukin-6 (Il-6), and Tumor necrosis factor α (Tnf-α)) were markedly decreased in lung tissues following drug treatment. Moreover, Van Gieson and sirius red staining data showed that collagen deposition of lung tissue was effectively suppressed by gefitinib or fostamatinib treatment in silicosis mice. Signal Transduct Target Ther. 2022 May 13;7(1):157
Mice Atg7+/− mice By gavage 200 mg/kg Once daily for 4 weeks To evaluate the hepatotoxicity of Gefitinib, results showed that Gefitinib significantly induced liver injury, and autophagy inhibition alleviated liver damage. Autophagy. 2021 Oct;17(10):3221-3237.
Nude mice H1975 tumor xenograft model Oral 100 mg/kg Once daily for 5 days To evaluate the anti-tumor effect of gefitinib in combination with Ad/ABE-TP53-EGFR, the results showed that the combination treatment significantly inhibited tumor growth and reversed gefitinib resistance. Mol Ther. 2024 Oct 2;32(10):3618-3628.

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00206414 BREAST CANCER Phase 2 Terminated(Difficulty accruing... More >> subjects the study accrual was closed) Less << - United States, Texas ... More >> Baylor Breast Center Houston, Texas, United States, 77030 Less <<
NCT00820417 Colorectal Cancer ... More >> Head and Neck Cancer Non Small Cell Lung Cancer (NSCLC) Less << Phase 1 Completed - Belgium ... More >> UZ Gasthuisberg Leuven, Belgium, 3000 Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Less <<
NCT00025207 Advanced Malignant Mesotheliom... More >>a Epithelial Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00027690 Recurrent Uterine Corpus Carci... More >>noma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT03381066 Completely Resected NSCLC With... More >> Common EGFR Mutations Less << Phase 3 Not yet recruiting December 2023 Korea, Republic of ... More >> Department of Oncology, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Byoung Chul Cho, MD    82 2 2228 0880    cbc1971@yuhs.ac Less <<
NCT01185158 Head and Neck Cancer Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60653 Less <<
NCT02929693 Cancer Phase 3 Enrolling by invitation June 2019 -
NCT03529084 Carcinoma, Non-small Cell Lung Phase 3 Withdrawn(strategic decision b... More >>y company) Less << May 31, 2024 -
NCT00322452 - Completed - -
NCT01864681 NSCLC EGFR Ge... More >>ne Amplification Advanced Cancer Stage IIIB NSCLC Stage IV NSCLC Less << Phase 2 Completed - China, Chongqing ... More >> Department of Respiratory Diseases, Daping Hospital, Third Military Medical University Chongqing, Chongqing, China, 400042 Less <<
NCT01039948 Carcinoma, Non-Small Cell-Lung... More >> Lung Neoplasms Lung Cancer Respiratory Tract Neoplasms Less << Phase 1 Phase 2 Completed - Hong Kong ... More >> Investigational Site 1 Shatin N.T., Hong Kong Korea, Republic of Investigational Site 2 Chungcheongbuk-do, Korea, Republic of Investigational Site 3 Gyeonggi-do, Korea, Republic of Investigational Site 4 Jeollanam-do, Korea, Republic of Investigational Site 5 Seoul, Korea, Republic of Investigational Site 6 Seoul, Korea, Republic of Investigational Site 7 Seoul, Korea, Republic of Investigational Site 8 Seoul, Korea, Republic of Malaysia Investigational Site 10 Kuala Lumpur, Malaysia Investigational Site 9 Kuala Lumpur, Malaysia Investigational Site 11 Pahang, Malaysia Philippines Investigational Site 12 Manila, Philippines Investigational Site 13 Pasig City, Philippines Investigational Site 14 Quezon City, Philippines Singapore Investigational Site 15 Singapore, Singapore Taiwan Investigational Site 16 Changhua, Taiwan Investigational Site 17 Chiayi, Taiwan Investigational Site 18 Taichung, Taiwan Investigational Site 19 Tainan, Taiwan Investigational Site 20 Taipei, Taiwan Investigational Site 21 Taipei, Taiwan Investigational Site 22 Taoyuan, Taiwan Thailand Investigational Site 23 Bangkok, Thailand Investigational Site 24 Chiang Mai, Thailand Investigational Site 25 KhonKaen, Thailand Investigational Site 26 Songkla, Thailand Less <<
NCT00322452 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00126555 Recurrent Skin Cancer ... More >> Squamous Cell Carcinoma of the Skin Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00104728 Lung Cancer TERMINATED 2025-03-09 H. Lee Moffitt Cancer Center a... More >>nd Research Institute, Tampa, Florida, 33612-9497, United States Less <<
NCT00104728 Lung Cancer TERMINATED 2025-03-09 H. Lee Moffitt Cancer Center a... More >>nd Research Institute, Tampa, Florida, 33612-9497, United States Less <<
NCT01769066 NSCLC Phase 2 Phase 3 Completed - China, Shanghai ... More >> Cancer hospital Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT02088112 Carcinoma, Non-Small-Cell Lung Phase 1 Active, not recruiting June 11, 2019 United States, Florida ... More >> Research Site Tampa, Florida, United States, 33612 United States, Texas Research Site Houston, Texas, United States, 77030 United States, Washington Research Site Seattle, Washington, United States, 98109 Japan Research Site Chuo-ku, Japan, 104-0045 Research Site Matsuyama-shi, Japan, 791-0280 Korea, Republic of Research Site Seoul, Korea, Republic of, 03080 Research Site Seoul, Korea, Republic of, 05505 Less <<
NCT00126555 - Completed - -
NCT01312337 Nonsmall Cell Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, Pf    822-3410-3459       Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju ahn, Pf    82-2-3410-3459    silkahn@skku.edu Less <<
NCT00127829 Tumors PHASE1 COMPLETED 2025-01-08 Research Site, Los Angeles, Ca... More >>lifornia, United States|Research Site, Palm Springs, California, United States Less <<
NCT00068497 Anaplastic Thyroid Cancer ... More >> Insular Thyroid Cancer Metastatic Parathyroid Cancer Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Basal Cell Carcinoma of the Lip Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Recurrent Lymphoepithelioma of the Nasopharynx Recurrent Lymphoepithelioma of the Oropharynx Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Recurrent Mucoepidermoid Carcinoma of the Oral Cavity Recurrent Non-small Cell Lung Cancer Recurrent Parathyroid Cancer Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Thyroid Cancer Recurrent Verrucous Carcinoma of the Larynx Stage III Follicular Thyroid Cancer Stage III Papillary Thyroid Cancer Stage III Salivary Gland Cancer Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Verrucous Carcinoma of the Larynx Stage IIIB Non-small Cell Lung Cancer Stage IV Lymphoepithelioma of the Nasopharynx Stage IV Non-small Cell Lung Cancer Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity Stage IVA Basal Cell Carcinoma of the Lip Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Stage IVA Follicular Thyroid Cancer Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Stage IVA Lymphoepithelioma of the Oropharynx Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity Stage IVA Papillary Thyroid Cancer Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity Stage IVB Basal Cell Carcinoma of the Lip Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Stage IVB Follicular Thyroid Cancer Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Stage IVB Lymphoepithelioma of the Oropharynx Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity Stage IVB Papillary Thyroid Cancer Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity Stage IVC Basal Cell Carcinoma of the Lip Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity Stage IVC Follicular Thyroid Cancer Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity Stage IVC Lymphoepithelioma of the Oropharynx Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity Stage IVC Papillary Thyroid Cancer Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Thryoid Gland Nonmedullary Carcinoma Thyroid Gland Medullary Carcinoma Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << Not Applicable Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT01818947 - Completed - United Kingdom ... More >> Queen Elizabeth Hospital Birmingham, United Kingdom Velindre Nhs Trust Cardiff, United Kingdom Harrogate District Hospital Harrogate, United Kingdom Leeds Teaching Hospitals Leeds, United Kingdom Liverpool Heart and Chest Hospital Liverpool, United Kingdom Mount Vernon Hospital Nhs Trust London, United Kingdom Royal Marsden Hospital London, United Kingdom University College Hospital London, United Kingdom Christie Hospital Nhs Trust Manchester, United Kingdom Nottingham University Hospitals Nhs Trust Nottingham, United Kingdom Northern General Hospital Sheffield, United Kingdom York District Hospital York, United Kingdom Less <<
NCT00040781 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01466660 Lung Neoplasms Phase 2 Active, not recruiting October 16, 2018 -
NCT00588445 Lung Cancer|Non-small Cell Lun... More >>g Cancer|Bronchioloalveolar Cancer Less << PHASE2 COMPLETED 2025-09-10 Memorial Sloan-Kettering Cance... More >>r Center, New York, New York, 10065, United States Less <<
NCT00588445 Lung Cancer|Non-small Cell Lun... More >>g Cancer|Bronchioloalveolar Cancer Less << PHASE2 COMPLETED 2025-09-10 Memorial Sloan-Kettering Cance... More >>r Center, New York, New York, 10065, United States Less <<
NCT00357734 Lung Cancer|Breast Cancer PHASE3 COMPLETED 2025-05-15 Research Site, Freiburg, Germa... More >>ny|Research Site, Gauting, Germany|Research Site, Gro?hansdorf, Germany|Research Site, Hemer, Germany|Research Site, Jena, Germany|Research Site, Minden, Germany|Research Site, Tübingen, Germany Less <<
NCT01466660 - Active, not recruiting - -
NCT02374645 Non-Small Cell Lung Cancer Phase 1 Active, not recruiting April 2018 China ... More >> Guangdong General Hospital Guangzhou, China, 510080 Less <<
NCT00357734 Lung Cancer|Breast Cancer PHASE3 COMPLETED 2025-05-15 Research Site, Freiburg, Germa... More >>ny|Research Site, Gauting, Germany|Research Site, Gro?hansdorf, Germany|Research Site, Hemer, Germany|Research Site, Jena, Germany|Research Site, Minden, Germany|Research Site, Tübingen, Germany Less <<
NCT03374280 Non Small Cell Lung Cancer Phase 2 Recruiting December 30, 2021 China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Recruiting Guangzhou, Guangdong, China, 510120 Contact: Haihong Yang, MD    0862083062825    bjrf2009@yahoo.com    Principal Investigator: Haihong Yang, Dr. Less <<
NCT02299765 Non-small Cell Lung Cancer Met... More >>astatic EGFR Activating Mutation Less << Phase 4 Terminated(the research data i... More >>s not statistically significant) Less << - China, Sichuan ... More >> China West Hospital Chengdu, Sichuan, China, 610000 Less <<
NCT00428896 Breast Cancer PHASE2 COMPLETED 2025-03-08 University Hospital of Crete, ... More >>Heraklion, Crete, 71110, Greece Less <<
NCT02338011 Non-Small Cell Lung Cancer ... More >> Brain Metastases EGFR Gene Mutation Less << Phase 2 Phase 3 Unknown November 2017 China, Shanghai ... More >> Varian linear accelerato Recruiting Shanghai, Shanghai, China, 200030 Contact: Liyan Jiang, M.D,Ph.D    18017321302    jiang_liyan2000@126.com Less <<
NCT00188617 LUNG CANCER Phase 2 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT00113529 Carcinoma, Renal Cell Phase 1 Phase 2 Completed - United States, Michigan ... More >> Pfizer Investigational Site Ann Arbor, Michigan, United States, 48109 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT00317772 Ovarian Cancer ... More >> Peritoneal Neoplasms Fallopian Tube Cancer Less << Phase 1 Phase 2 Active, not recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02148380 Non-Small-Cell Lung Cancer Not Applicable Completed - China ... More >> Shanghai Chest Hospital Shanghai, China, 200030 Less <<
NCT00452244 Lung Cancer Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of Less <<
NCT00113529 - Completed - -
NCT02447419 Solid Tumor PHASE2 COMPLETED 2020-12-01 Samsung Medical Center, Seoul,... More >> Korea, Republic of Less <<
NCT00268346 Esophageal Cancer PHASE2 COMPLETED 2025-08-11 Cleveland Clinic Taussig Cance... More >>r Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, 44195, United States Less <<
NCT00071994 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT02484755 Cushing's Disease|Corticotroph... More >>in Adenoma Less << PHASE2 UNKNOWN - Huashan Hospital, Shanghai, Sh... More >>anghai, 200040, China Less <<
NCT00509002 Salivary Gland Cancer PHASE2 COMPLETED 2025-09-16 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00268346 Esophageal Cancer PHASE2 COMPLETED 2025-08-11 Cleveland Clinic Taussig Cance... More >>r Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, 44195, United States Less <<
NCT01469000 Carcinoma, Non Small Cell Lung Phase 2 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sichuan, China, 610041 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 650-0046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 228-0329 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 710-8602 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 411-8777 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 104-0045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 755-0241 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cheong Ju-City, Korea, Republic of, 361-711 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 135 720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-723 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jhonghe City, Taiwan, 235 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kaohsiung, Taiwan, 824 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Keelung, Taiwan, 204 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Niao Sung Hsiang, Taiwan, 833 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 40705 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 Less <<
NCT01469000 - Completed - -
NCT01024413 Thoracic Neoplasms Phase 3 Completed - China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT00509002 Salivary Gland Cancer PHASE2 COMPLETED 2025-09-16 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00483561 Prostate Cancer Phase 2 Terminated(PI left UNMC) - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT00483561 - Terminated(PI left UNMC) - -
NCT01404260 Non-small Cell Lung Cancer Phase 3 Completed - China, Shanghai ... More >> Shanghai Lung Tumor Clinical Center,Shanghai Chest Hospital Shanghai, Shanghai, China, 200030 Less <<
NCT01783834 Previous Treated Metastatic No... More >>n-small Cell Lung Cancer Less << Phase 2 Completed - Korea, Republic of ... More >> Gachon university Gil Medical Center Incheon, Korea, Republic of Less <<
NCT02319577 Non Small Cell Lung Cancer Phase 2 Unknown December 2015 Italy ... More >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genova, Italy, 16132 Contact: Francesco Grossi, MD    +39 010 5600385    francesco.grossi@hsanmartino.it Less <<
NCT01017679 Non-small Cell Lung Cancer Phase 2 Completed - China, Guangdong ... More >> Cancer Center of Sun-Yat Sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT00681967 Head and Neck Cancer Phase 1 Completed - Switzerland ... More >> Research Site Basel, Switzerland Research Site Bern, Switzerland Less <<
NCT02930954 Non-small-cell Lung Cancer Phase 2 Unknown December 2018 China ... More >> Department of Oncology, Shanghai pulmonary hospital Shanghai, China, 200433 Less <<
NCT01774721 Non-small Cell Lung Cancer Wit... More >>h EGFR-Activating Mutations Less << Phase 3 Active, not recruiting March 29, 2019 -
NCT01391260 Non-small Cell Lung Cancer Phase 2 Unknown July 2017 China, Beijing ... More >> 307 Hosptial of PLA Recruiting Beijing, Beijing, China, 100000 Principal Investigator: Ge Shen          Chinese Academy of Medical Sciences Cancer Hospital Recruiting Beijing, Beijing, China, 266000 Principal Investigator: Lvhua Wang          China, Hubei Renmin Hospital of Wuhan University, Hubei General Hospital Recruiting Wuhan, Hubei, China, 430060 Principal Investigator: Qibin Song          China, Shanghai Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200000 Principal Investigator: Min Fan          China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310000 Principal Investigator: Shenglin Ma          China Beijing Cancer Hospital Recruiting Beijing, China, 100000 Contact: Guangying Zhu       zgypu@yahoo.com.cn    Contact: Rong Yu       yurong311@yahoo.cn    Principal Investigator: Guangying Zhu Less <<
NCT01404260 - Completed - -
NCT01513174 Non Small Cell Lung Cancer Phase 1 Phase 2 Completed - Spain ... More >> H. Germans Trias i Pujol Badalona, Barcelona, Spain ICO Hospitalet Hospitalet, Barcelona, Spain H. Gen. Universitario de Alicante Alicante, Spain H. Vall d'Hebrón Barcelona, Spain H. Teresa Herrera La Coruña, Spain Less <<
NCT01951469 Non-small Cell Lung Cancer ... More >> Brain Metastases EGFR Mutation Less << Phase 2 Recruiting June 2019 China, Guangdong ... More >> Sun Yat-sen University of Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: li-kun Chen, doctor    13798019964    chenlk@sysucc.org.cn    Principal Investigator: li-kun Chen, doctor Less <<
NCT01147211 Non Small Cell Lung Cancer Phase 1 Unknown December 2013 Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT03264794 Non-small Cell Lung Cancer Phase 4 Not yet recruiting June 2022 -
NCT00614809 Non-Small Cell Lung Cancer ... More >> Brain Metastasis Less << Phase 2 Unknown December 2010 -
NCT03122717 Non-Small Cell Lung Cancer Phase 1 Recruiting April 2023 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel Costa, MD, PhD       dbcosta@bidmc.harvard.edu    Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Pasi Janne, MD, PhD    617-632-6036    Pasi_Janne@dfci.harvard.edu    Principal Investigator: Pasi Janne, MD, PhD Less <<
NCT01774721 - Active, not recruiting - -
NCT01203917 Caucasian Patients With EGFR M... More >>utation Positive Advanced NSCLC Less << PHASE4 COMPLETED 2025-06-16 Research Site, Plovdiv, Bulgar... More >>ia|Research Site, Sofia, Bulgaria|Research Site, Stara Zagora, Bulgaria|Research Site, Varna, Bulgaria|Research Site, Vratza, Bulgaria|Research Site, ANGERS Cedex 9, France|Research Site, Saint Herblain Cedex, France|Research Site, Athens, Greece|Research Site, Heraklion, Greece|Research Site, Larissa, Greece|Research Site, Thessaloniki, Greece|Research Site, Budapest, Hungary|Research Site, Deszk, Hungary|Research Site, Edelény, Hungary|Research Site, Gy?r, Hungary|Research Site, Mosdós, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Ancona, Italy|Research Site, Carpi, Italy|Research Site, Livorno, Italy|Research Site, Perugia, Italy|Research Site, Oslo, Norway|Research Site, Stavanger, Norway|Research Site, Trondheim, Norway|Research Site, Gdańsk, Poland|Research Site, Kraków, Poland|Research Site, Lubin, Poland|Research Site, Olsztyn, Poland|Research Site, Otwock, Poland|Research Site, Szczecin, Poland|Research Site, Toruń, Poland|Research Site, Warszawa, Poland|Research Site, Wroc?aw, Poland|Research Site, Coimbra, Portugal|Research Site, Lisboa, Portugal|Research Site, Porto, Portugal|Research Site, Vila Nova de Gaia, Portugal|Research Site, Brasov, Romania|Research Site, Bucharest, Romania|Research Site, Bucuresti, Romania|Research Site, Cluj Napoca, Romania|Research Site, Constanta, Romania|Research Site, Lugo, Spain|Research Site, Lérida, Spain|Research Site, Madrid, Spain|Research Site, Majadahonda, Spain|Research Site, Málaga, Spain|Research Site, Basel, Switzerland|Research Site, Chur, Switzerland|Research Site, Rapperswil-Jona, Switzerland|Research Site, Sursee, Switzerland|Research Site, Ankara, Turkey|Research Site, Istanbul, Turkey|Research Site, Izmir, Turkey|Research Site, Aberdeen, United Kingdom|Research Site, Birmingham, United Kingdom|Research Site, Burnley, United Kingdom|Research Site, Cambridge, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, Nottingham, United Kingdom|Research Site, Wolverhampton, United Kingdom Less <<
NCT01291823 Esophageal Cancer Phase 2 Unknown December 2014 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xu yaping, MD    0086-571-88122    xuyaping1207@gmail.com Less <<
NCT03267654 Non-small-cell Lung Cancer Phase 2 Recruiting August 20, 2019 China, Shanghai ... More >> Shanghai Pulmonary Hospital; Recruiting Shanghai, Shanghai, China, 200000 Contact: Caicun Zhou, MD Less <<
NCT00212108 Nasopharyngeal Carcinoma Phase 1 Phase 2 Completed - Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Less <<
NCT01749072 Non-small Cell Lung Cancer ... More >> Effects of Chemotherapy Less << Phase 2 Unknown December 2017 China, Beijing ... More >> Department of Respiratory Medicine, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039 ext +86    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206 ext +86    pumchzj@sina.com    Sub-Investigator: Wei Zhong, MD          Sub-Investigator: Jinmei Luo, MD Less <<
NCT00519077 Head and Neck Neoplasms PHASE2 COMPLETED 2025-05-13 University of Miami Sylvester ... More >>Comprehensive Cancer Center, Miami, Florida, 33136, United States|Northwestern University, Chicago, Illinois, 60611, United States Less <<
NCT00519077 Head and Neck Neoplasms PHASE2 COMPLETED 2025-05-13 University of Miami Sylvester ... More >>Comprehensive Cancer Center, Miami, Florida, 33136, United States|Northwestern University, Chicago, Illinois, 60611, United States Less <<
NCT00770588 Non-small Cell Lung Cancer (NS... More >>CLC) Less << Phase 4 Completed - China, Beijing ... More >> Research Site Beijing, Beijing, China China, Fujian Research Site Fuzhou, Fujian, China China, Guangdong Research Site Guangzhou, Guangdong, China China, Guangxi Research Site Nanning, Guangxi, China China, Henan Research Site Zhengzhou, Henan, China China, Hubei Research Site Wuhan, Hubei, China China, Jiangsu Research Site Nanjing, Jiangsu, China China, Jilin Research Site Changchun, Jilin, China China, Liaoning Research Site Shengyang, Liaoning, China China, Shanghai Research Site Shanghai, Shanghai, China China, Shanxi Research Site Xi'an, Shanxi, China China, Sichuan Research Site Chengdu, Sichuan, China China, Tianjin Research Site Tianjin, Tianjin, China China, Zhejiang Research Site Hangzhou, Zhejiang, China Less <<
NCT00770588 - Completed - -
NCT01871480 Non-Small Cell Lung Cancer Phase 2 Terminated May 2016 China, Yunnan ... More >> Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medicine University Kunming, Yunnan, China, 650118 Less <<
NCT02518802 Lung Neoplasms Phase 3 Recruiting January 2020 China, Shaanxi ... More >> Tangdu Hospital of the Fourth Millitary Medical University Recruiting Xi'an, Shaanxi, China, 710038 Contact: Li Xiaofei, MD    +8629,84777436    lxfchest@fmmu.edu.cn    Contact: Yan Xiaolong, MD    +862984717558    yanxiaolong@fmmu.edu.cn Less <<
NCT01570296 Non-Small Cell Lung Cancer ... More >> Solid Tumors Less << Phase 1 Active, not recruiting April 2019 Singapore ... More >> National Cancer Centre Singapore Singapore, Singapore, 169610 Less <<
NCT01732276 Breast Cancer Phase 2 Unknown October 2015 -
NCT00130702 Myelogenous Leukemia, Acute Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01755923 Non-small Cell Lung Cancer Phase 2 Unknown December 2014 China, Beijing ... More >> Department of Respiratory Medicine, Peking Union Medical College Hospita Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039 ext +86    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206 ext +86    pumchzj@sina.com    Sub-Investigator: Wei Zhong, MD          Sub-Investigator: Jinmei Luo, MD Less <<
NCT00372515 Non-Small Cell Lung Cancer PHASE1 COMPLETED 2025-04-15 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less <<
NCT02040064 Non Small Cell Lung Cancer Phase 1 Completed - France ... More >> Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT02151721 Non-Small-Cell Lung Carcinoma Phase 1 Active, not recruiting February 20, 2018 Japan ... More >> Nagoya University Graduate School of Medicine Nagoya, Aichi, Japan, 466-8560 Institute of Biomedical Research and Innovation Hospital Kobe, Hyogo-ken, Japan, 650-0047 Kanazawa University Hospital Kanazawa, Ishikawa, Japan, 920-0934 Tohoku University Hospital Sendai, Miyagi, Japan, 980-8574 Shizuoka Cancer Center Sunto-gun, Shizuoka, Japan, 411-8777 Less <<
NCT01405079 Non-small Cell Lung Cancer Phase 3 Active, not recruiting December 2020 China ... More >> Guangdong General Hospital Guangzhou, China Less <<
NCT01203917 Caucasian Patients With EGFR M... More >>utation Positive Advanced NSCLC Less << PHASE4 COMPLETED 2025-06-16 Research Site, Plovdiv, Bulgar... More >>ia|Research Site, Sofia, Bulgaria|Research Site, Stara Zagora, Bulgaria|Research Site, Varna, Bulgaria|Research Site, Vratza, Bulgaria|Research Site, ANGERS Cedex 9, France|Research Site, Saint Herblain Cedex, France|Research Site, Athens, Greece|Research Site, Heraklion, Greece|Research Site, Larissa, Greece|Research Site, Thessaloniki, Greece|Research Site, Budapest, Hungary|Research Site, Deszk, Hungary|Research Site, Edelény, Hungary|Research Site, Gy?r, Hungary|Research Site, Mosdós, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Ancona, Italy|Research Site, Carpi, Italy|Research Site, Livorno, Italy|Research Site, Perugia, Italy|Research Site, Oslo, Norway|Research Site, Stavanger, Norway|Research Site, Trondheim, Norway|Research Site, Gdańsk, Poland|Research Site, Kraków, Poland|Research Site, Lubin, Poland|Research Site, Olsztyn, Poland|Research Site, Otwock, Poland|Research Site, Szczecin, Poland|Research Site, Toruń, Poland|Research Site, Warszawa, Poland|Research Site, Wroc?aw, Poland|Research Site, Coimbra, Portugal|Research Site, Lisboa, Portugal|Research Site, Porto, Portugal|Research Site, Vila Nova de Gaia, Portugal|Research Site, Brasov, Romania|Research Site, Bucharest, Romania|Research Site, Bucuresti, Romania|Research Site, Cluj Napoca, Romania|Research Site, Constanta, Romania|Research Site, Lugo, Spain|Research Site, Lérida, Spain|Research Site, Madrid, Spain|Research Site, Majadahonda, Spain|Research Site, Málaga, Spain|Research Site, Basel, Switzerland|Research Site, Chur, Switzerland|Research Site, Rapperswil-Jona, Switzerland|Research Site, Sursee, Switzerland|Research Site, Ankara, Turkey|Research Site, Istanbul, Turkey|Research Site, Izmir, Turkey|Research Site, Aberdeen, United Kingdom|Research Site, Birmingham, United Kingdom|Research Site, Burnley, United Kingdom|Research Site, Cambridge, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, Nottingham, United Kingdom|Research Site, Wolverhampton, United Kingdom Less <<
NCT03602027 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Not Applicable Not yet recruiting February 1, 2019 -
NCT03599518 Non Small Cell Lung Cancer Phase 1 Recruiting March 2021 Japan ... More >> National Cancer Center Hospital East Recruiting Kashiwa, Chiba, Japan, 277-8577 Contact: See Central Contact          Kindai University Hospital Recruiting Sayama, Osaka, Japan, 589-8511 Contact: See Central Contact          The Cancer Institute Hospital of Japanese Foundation For Cancer Research Recruiting Ariake, Tokyo, Japan, 135-8550 Contact: See Central Contact          National Cancer Center Hospital Recruiting Tsukiji, Tokyo, Japan, 104-0045 Contact: See Central Contact          Kyushu University Hospital Recruiting Fukuoka, Japan, 812-8582 Contact: See Central Contact          Shizuoka Cancer Center Recruiting Shizuoka, Japan, 411-8777 Contact: See Central Contact Less <<
NCT02951637 Lung Adenocarcinoma Phase 2 Not yet recruiting December 2019 -
NCT01498562 Non Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 2 Completed - Korea, Republic of ... More >> Severance hospital, Yonsei Cancer Center Seoul, Korea, Republic of Less <<
NCT03647592 - Recruiting June 1, 2019 China, Hunan ... More >> Hunan Provincal Tumor Hospital Recruiting Changsha, Hunan, China, 410013 Contact: Nong Yang, MD    +86 731 89762323    yangnong0217@163.com    Contact: Chunhua Zhou, MD    +86 731 89762321    zhouchunhua@hnszlyy.com    Sub-Investigator: Nong Yang, MD Less <<
NCT02347839 Lung Cancer Phase 2 Recruiting January 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Si-Yu Wang, Doctor    +86 20 87343439    wsysums@163.net Less <<
NCT03050164 Bioequivalence Study Phase 1 Completed - -
NCT03399669 Non-small Cell Lung Cancer Phase 2 Active, not recruiting December 31, 2018 Korea, Republic of ... More >> Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Less <<
NCT01485809 Squamous Cell Carcinoma of Bro... More >>nchus Less << PHASE2 COMPLETED 2025-11-16 Seoul Veterans Hospital, Seoul... More >>, 134-791, Korea, Republic of Less <<
NCT01530334 Lung Cancer Phase 2 Completed - Italy ... More >> Research Site Alessandria, Italy Research Site Bologna, Italy Research Site Brescia, Italy Research Site Cona, Italy Research Site Firenze, Italy Research Site Genova, Italy Research Site Lecce, Italy Research Site Macerata, Italy Research Site Meldola, Italy Research Site Milano, Italy Research Site Monza, Italy Research Site Napoli, Italy Research Site Novara, Italy Research Site Parma, Italy Research Site Perugia, Italy Research Site Pordenone, Italy Research Site Ravenna, Italy Research Site Rimini, Italy Research Site Roma, Italy Research Site Rozzano, Italy Research Site Torino, Italy Research Site Treviso, Italy Research Site Udine, Italy Research Site Verona, Italy Less <<
NCT00986284 Non Small Cell Lung Cancer Phase 2 Suspended(Lack of patients and... More >> some progressed disease soon after surgery) Less << November 2016 China, Tianjin ... More >> Tianjin Cancer Institute & Hospital Tianjin, Tianjin, China, 300060 Less <<
NCT03050177 Healthy Phase 1 Completed - -
NCT01530334 - Completed - -
NCT01933347 Non Small Cell Lung Cancer PHASE2 COMPLETED 2018-04-10 Nanjing General Hospital of Na... More >>njing Military Command, Nanjing, Jiangsu, 210002, China Less <<
NCT01965275 Self Efficacy ... More >> Drug Toxicity Less << Phase 2 Recruiting December 2017 China, Anhui ... More >> Dept. of Oncology,The First Affiliated Hospital of Anhui Medical Univesrsity Recruiting Hefei, Anhui, China, 230032 Contact: Yanzhe Zhu, MD    8655162922987    yanzhe918@163.com    Principal Investigator: Yueyin Pan, MD Less <<
NCT00809237 Non-small Cell Lung Cancer Phase 1 Phase 2 Unknown November 2014 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Tan Min Chin, MD    65-67724140    Tan_Min_CHIN@nuhs.com.sg    Contact: Boon Cher Goh, MD    65-67724140    Boon_Cher_GOH@nuhs.com.sg    Principal Investigator: Tan Min Chin, MD Less <<
NCT02976116 NSCLC Phase 2 Active, not recruiting October 2019 China, Shanghai ... More >> Shanghai Chest Hospital Shanghai, Shanghai, China China The First Hospital of Zhejiang University Hangzhou, China Less <<
NCT00824746 - Completed - -
NCT01833572 Non-small-cell Lung Cancer PHASE2 COMPLETED 2025-10-15 Fudan University Shanghai Canc... More >>er Center, Shanghai, 200032, China Less <<
NCT02824458 EGFR Tyrosine Kinase Inhibitor... More >>s Plus VEGFR Inhibitors Less << Phase 3 Recruiting December 2023 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Hongyun Zhao, PhD    86-20-8734 2482    zhaohy@sysucc.org.cn Less <<
NCT03758287 Non-small Cell Lung Cancer Phase 1 Phase 2 Recruiting November 17, 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Li Zhang, MD          Principal Investigator: Li Zhang, MD Less <<
NCT03292133 Lung Cancer Phase 2 Recruiting March 31, 2025 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Beth Kennedy    617-724-1223    EAKENNEDY@mgh.harvard.edu    Principal Investigator: Zofia Piotrowska, MD Less <<
NCT02282267 Lung Adenocarcinoma UNKNOWN 2025-02-18 beijing Cancer Hospital, Beiji... More >>ng, China Less <<
NCT01510990 Non-small Cell Lung Cancer PHASE2 UNKNOWN 2025-11-15 Asan Medical Center, Seoul, 13... More >>8-736, Korea, Republic of Less <<
NCT03381430 Lung Cancer NOT_YET_RECRUITING 2025-12-25 China-Japan Friendship Hospita... More >>l, Beijing, China Less <<
NCT00824746 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun-gun, Jeonnam, Korea, Republic of, 519-809 Less <<
NCT03486496 Lung Adenocarcinoma ... More >> EGFR Mutation Less << Phase 2 Not yet recruiting February 1, 2020 China, Fujian ... More >> Fujian cancer hospital Fuzhou, Fujian, China Less <<
NCT03457337 EGFR-sensitive Mutation-positi... More >>ve Advanced Non-squamous Non-small Cell Lung Cancer Treated With S-1plus Gefitinib Versus Gefitinib Monotherapy Less << Phase 2 Not yet recruiting January 28, 2021 -
NCT02804776 Non-small Cell Lung Cancer PHASE2 COMPLETED 2018-02-21 National Cancer Centre, Singap... More >>ore, 169610, Singapore Less <<
NCT03157310 Overal Survival, Non-small Cel... More >>l Lung Cancer Less << COMPLETED 2015-07-12 -
NCT00006048 Lung Cancer Phase 3 Unknown - United States, Delaware ... More >> AstraZeneca Pharmaceuticals LP Wilmington, Delaware, United States, 19850-5437 Less <<
NCT00282100 Liver Cancer Phase 2 Unknown December 2012 Singapore ... More >> Johns Hopkins Singapore International Center Singapore, Singapore, 308433 Less <<
NCT00238628 Lung Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00025142 Colorectal Cancer Phase 2 Completed - United States, California ... More >> Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305 Less <<
NCT00656136 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT00091247 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Not Applicable Completed - -
NCT00656136 - Completed - -
NCT00258323 Esophageal Cancer Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00290719 Esophageal Cancer Phase 1 Terminated(low enrollment) - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00319787 Locally Advanced Prostate Canc... More >>er Less << Phase 2 Completed - Norway ... More >> Research Site Moelv, Norway Research Site Oslo, Norway Research Site Trondheim, Norway Less <<
NCT00093652 Esophageal Cancer Phase 1 Phase 2 Terminated - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01932229 NSCLC Phase 2 Unknown - Israel ... More >> Sheba Medical Center Recruiting Ramat Gat, Israel, 52621 Contact: Dina Vornstein       Diana.Vorenshtein@sheba.health.gov.il    Principal Investigator: Jair Bar, MD-PhD Less <<
NCT00026364 Colorectal Cancer Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00049062 Breast Cancer Phase 2 Completed - United States, Texas ... More >> Cancer Therapy and Research Center San Antonio, Texas, United States, 78229 Less <<
NCT01994057 - Recruiting October 2018 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Shuang Xin, PHD    +86 13580479553    xshuang@mail2.sysu.edu.cn    Contact: Wei Feng, PHD    +86 15521329809    m18356069145@163.com    Principal Investigator: Min Huang, Professor Less <<
NCT00233636 Head and Neck Cancer ... More >> Carcinoma, Squamous Cell Less << Phase 2 Withdrawn - Italy ... More >> Research Site Aviano, Italy Research Site Azienda, Italy Research Site Milano, Italy Research Site Napoli, Italy Research Site Palermo, Italy Research Site Ragusa, Italy Less <<
NCT00234416 Pancreatic Cancer Phase 1 Phase 2 Completed - Spain ... More >> Research Site Barcelona, Spain Research Site Valencia, Spain Less <<
NCT00319618 Metastatic Breast Cancer Phase 2 Completed - Norway ... More >> Research Site Oslo, Norway Less <<
NCT00193336 Lung Cancer PHASE2 COMPLETED 2025-09-05 -
NCT01720901 Non-small Cell Lung Cancer Phase 4 Suspended(Accrual limitations) December 2016 China, Hunan ... More >> Xiangya Hospital, Central-South Univercity Changsha, Hunan, China, 410008 Less <<
NCT00084708 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00252798 Non Small Cell Lung Carcinoma Phase 1 Completed - Australia, Queensland ... More >> Research Site Woolloonabba, Queensland, Australia Australia, Victoria Research Site East Melbourne, Victoria, Australia Less <<
NCT02747953 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT00087334 Colorectal Cancer Phase 1 Phase 2 Terminated(Withdrawn due to po... More >>or/low accrual) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00242749 Cancer of Head and Neck Phase 2 Completed - Spain ... More >> Research Site Badalona, Spain Research Site Murcia, Spain Research Site Málaga, Spain Research Site Santander, Spain Less <<
NCT00186979 Solid Tumors Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00215995 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Puerto Rico Ponce School of Medicine Ponce, Puerto Rico, 00732 University of Puetro Rico Cancer Center San Juan, Puerto Rico, 00936-5067 Less <<
NCT00570401 Lung Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00570401 - Completed - -
NCT00090675 Non-Small-Cell Lung Carcinoma PHASE3 WITHDRAWN 2025-11-07 -
NCT00522145 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, California ... More >> Ronald Yanagihara Gilroy, California, United States, 95020 University of California Davis Cancer Center Sacramento, California, United States, 95817 Oncology Division and General Clincial Research, Stanford University Medical Center Stanford, California, United States, 94305 United States, Indiana Cancer Care Center, Inc. P.C. New Albany, Indiana, United States, 47150 United States, Maryland Washington County Hospital, The Center for Clinical Research Hagerstown, Maryland, United States, 21740 United States, Michigan Wayne State University, Wertz Clinical Cancer Center, Karmanos Center Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina New Bern Cancer Care Oncology New Bern, North Carolina, United States, 28560 United States, Ohio Case Western Reserve University, University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Signal Point Clinical Research Center Middletown, Ohio, United States, 45042 Less <<
NCT00255463 Breast Cancer Phase 2 Completed - Czech Republic ... More >> Research Site Brno, Czech Republic Research Site Chomutov, Czech Republic Research Site Ostrava - Poruba, Czech Republic Research Site Ostrava, Czech Republic Research Site Praha 2, Czech Republic France Research Site Clermont Ferrand, France Research Site Montpellier Cedex 5, France Research Site Tours Cedex, France Research Site Villejuif Cedex, France Hungary Research Site Budapest, Hungary Research Site Debrecen, Hungary Research Site Kecskemet, Hungary Portugal Research Site Coimbra, Portugal Research Site Funchal, Portugal Research Site Lisboa, Portugal Spain Research Site Santiago de Compostela, A Coruña, Spain Research Site Jaen, Jaén, Spain Research Site A Coruna, Spain Research Site Sevilla, Spain Research Site Valencia, Spain Research Site Zaragoza, Spain Sweden Research Site Göteborg, Sweden Research Site Molndal, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Chelmsford, Essex, United Kingdom Research Site Bournemouth, United Kingdom Research Site Croydon, United Kingdom Research Site Dundee, United Kingdom Research Site Leeds, United Kingdom Research Site Liverpool, United Kingdom Research Site London, United Kingdom Research Site Manchester, United Kingdom Research Site Newcastle Upon Tyne, United Kingdom Research Site Poole, United Kingdom Less <<
NCT00103051 Lung Cancer Phase 2 Completed - Netherlands ... More >> Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands Less <<
NCT00409006 Non-small Cell Lung Cancer Phase 2 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China, 350014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 201900 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT00234429 Colorectal Cancer Phase 2 Phase 3 Completed - Spain ... More >> Research Site A Coruna, Spain Research Site Barcelona, Spain Research Site Burgos, Spain Research Site Gijon, Spain Research Site Leon, Spain Research Site Madrid, Spain Research Site Oviedo, Spain Research Site Pamplona, Spain Research Site Valladolid, Spain Less <<
NCT00268255 Non-small Cell Lung Cancer Phase 1 Phase 2 Withdrawn(Study never moved fo... More >>rward with accrual.) Less << - -
NCT00239304 Head and Neck Neoplasms Phase 1 Phase 2 Completed - Finland ... More >> Research Centre Helsinki, Finland Less <<
NCT00242788 Colorectal Cancer Phase 1 Phase 2 Completed - Spain ... More >> Research Site Gerona, Spain Research Site Leganes, Spain Research Site Madrid, Spain Research Site Malaga, Spain Research Site Santander, Spain Research Site Zaragoza, Spain Less <<
NCT03653546 Non-small Cell Lung Cancer ... More >> EGFR Gene Mutation Brain Metastases Less << Phase 2 Phase 3 Recruiting October 16, 2021 -
NCT00234468 Non Small Cell Lung Carcinoma Phase 3 Terminated(Closed due to insuf... More >>ficient recruitment) Less << - Italy ... More >> Research Site Avellino, Italy Research Site Bergamo, Italy Research Site Bologna, Italy Research Site Cagliari, Italy Research Site Campobasso, Italy Research Site Catania, Italy Research Site Catanzaro, Italy Research Site Chieti, Italy Research Site Cosenza, Italy Research Site Della Fratte, Italy Research Site Emilia, Italy Research Site Fano, Italy Research Site Firenze, Italy Research Site Forli, Italy Research Site Frattamaggiore, Italy Research Site Livorno, Italy Research Site Messina, Italy Research Site Milano, Italy Research Site Napoli, Italy Research Site Novara, Italy Research Site Orbassano, Italy Research Site Padova, Italy Research Site Palermo, Italy Research Site Pavia, Italy Research Site Potenza, Italy Research Site Ravenna, Italy Research Site Rimini, Italy Research Site Roma, Italy Research Site San Giovanni Rotondo, Italy Research Site Sassari, Italy Research Site Taormina, Italy Research Site Venezia-Mestre, Italy Less <<
NCT00242918 Prostate Cancer Phase 2 Completed - United States, Washington ... More >> Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT00193284 Head and Neck Cancer Phase 2 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00195078 Head and Neck Cancer Phase 1 Phase 2 Terminated - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT00409006 - Completed - -
NCT02179671 Locally Advanced or Metastatic... More >> Non-Small-Cell Lung Cancer (Stage IIIB-IV) Less << Phase 2 Completed - United States, Arizona ... More >> Research Site Goodyear, Arizona, United States United States, District of Columbia Research Site Washington, District of Columbia, United States United States, Georgia Research Site Augusta, Georgia, United States Research Site Marietta, Georgia, United States United States, Kentucky Research Site Ashland, Kentucky, United States United States, Missouri Research Site St Louis, Missouri, United States United States, New York Research Site Mineola, New York, United States United States, North Carolina Research Site Huntersville, North Carolina, United States United States, Washington Research Site Spokane, Washington, United States Research Site Tacoma, Washington, United States Less <<
NCT01024712 Lung Cancer Phase 2 Unknown - China ... More >> Cancer Institute Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 Contact: Yuankai Shi, MD, PhD    86-10-137-0125-1865 Less <<
NCT02856893 NSCLC Phase 2 Recruiting December 2027 France ... More >> Gustave Roussy Recruiting Paris, France Jordan King Hussein Cancer Center Recruiting Amman, Jordan Contact: Kamal Al-Rabi       ka.10798@khcc.jo    Poland Medical University of Gdansk Not yet recruiting Gdansk, Poland Less <<
NCT00185835 Head and Neck Cancer ... More >> Carcinoma, Squamous Cell Less << Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00717847 - Completed - Singapore ... More >> National University Hospital Singapore, Singapore Less <<
NCT00025116 Prostate Cancer Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Ontario Cancer Institute Toronto, Ontario, Canada, M4X 1K9 Less <<
NCT00030524 Colorectal Cancer Phase 2 Completed - United States, Texas ... More >> Institute for Drug Development San Antonio, Texas, United States, 78229 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 Less <<
NCT00016991 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00020709 Adenocarcinoma of the Lung ... More >> Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 3 Completed - United States, Texas ... More >> Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States, 78245 Less <<
NCT00049556 Cervical Cancer ... More >> Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT00012337 Kidney Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00083057 Head and Neck Cancer Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Metabolism Branch;MET Bethesda, Maryland, United States, 20892-1547 Less <<
NCT00062270 Lung Cancer Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3300 Less <<
NCT00027625 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75390-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00098462 Lung Cancer Phase 1 Phase 2 Withdrawn(Withdrawn as study n... More >>ever opened) Less << - -
NCT00198380 Pneumonic-type Adenocarcinoma ... More >>(P-ADC)|Lung Adenocarcinoma With Bronchiolo-alveolar Feature Less << PHASE2 COMPLETED 2025-12-09 CHU Besancon - Pneumologie, Be... More >>sancon, 25000, France|APHP - CHU Avicenne - Oncologie Medicale, Bobigny, 93000, France|Centre F. Baclesse, Caen, 14000, France|CHU - Pneumologie, Caen, 14000, France|CHU Grenoble - pneumologie, Grenoble, 38000, France|HCL - Croix-Rousse, Lyon, 69000, France|APHP - Saint-Antoine - pneumologie, Paris, 75012, France|Hopital Tenon - Pneumologie, Paris, 75020, France|HCL - Lyon Sud (Pneumologie), Pierre Bénite, 69495, France|CHU Saint-Etienne Pneumologie, Saint-Etienne, 42000, France|CHU Lyautey - Pneumologie, Strasbourg, 63000, France Less <<
NCT00014183 Kidney Cancer Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Veterans Affairs Medical Center - Baltimore Baltimore, Maryland, United States, 21201 Less <<
NCT00255476 Squamous Cell Cancer ... More >> Cancer of Head and Neck Less << Phase 2 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT00264498 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - Canada, Quebec ... More >> Research Site Montreal, Quebec, Canada Less <<
NCT01167244 Non-Small-Cell Lung Carcinoma Phase 2 Completed - Japan ... More >> Local Institution Kashiwa-Shi, Chiba, Japan, 2778577 Local Institution Osaka-Sayama-Shi, Osaka, Japan, 5898511 Local Institution Sunto-Gun, Shizuoka, Japan, 4118777 Local Institution Koto-Ku, Tokyo, Japan, 1358550 Less <<
NCT00264498 - Completed - -
NCT00181688 Ovarian Cancer ... More >> Peritoneal Carcinoma Tubal Carcinoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00198159 Refractory Germ Cell Tumors Ex... More >>pressing EGRF Less << Phase 2 Terminated - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00258297 Esophageal Cancer Phase 2 Terminated(Withdrawn for lack ... More >>of funding and accrual) Less << - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00084786 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01130961 - Completed - Thailand ... More >> Research Site Bangkok, Thailand Less <<
NCT00144066 Lung Cancer Phase 3 Completed - -
NCT00239291 Non-Metastatic Prostate Cancer Phase 1 Phase 2 Completed - Finland ... More >> Research site Helsinki, Finland Less <<
NCT00066339 Breast Cancer Phase 2 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Less <<
NCT00310154 Lung Cancer Phase 1 Completed - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT00319800 Non-Small Cell Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> Gachon University Gil Medical Center Incheon, Korea, Republic of, 405 760 Less <<
NCT01103089 - Completed - Netherlands ... More >> Research Site Amsterdam, Netherlands Research Site Apeldoorn, Netherlands Research Site Den Haag, Netherlands Research Site Groningen, Netherlands Research Site Helmond, Netherlands Research Site Hengelo, Netherlands Research Site Hoofddorp, Netherlands Research Site Leiden, Netherlands Research Site Veldhoven, Netherlands Research Site Venlo, Netherlands Research Site Zutphen, Netherlands Less <<
NCT00247481 Breast Cancer Phase 2 Completed - France ... More >> Research Site Dijon, France Research Site Paris, France Research Site Saint Cloud, France Research Site Saint Germain en Laye, France Research Site Villejuif Cedex, France Less <<
NCT00250887 Recurrent Glioblastoma Phase 2 Completed - Switzerland ... More >> University Hospital Zürich Zürich, Switzerland, 8091 Less <<
NCT00234442 Brain Neoplasms ... More >> Non Small Cell Lung Cancer Less << Phase 2 Terminated(Closed due to insuf... More >>ficient recruitment.) Less << - Italy ... More >> Research Site Bologna, Italy Research Site Orbassano, Italy Research Site Parma, Italy Research Site Rozzano, Italy Less <<
NCT00217698 Lung Cancer Phase 2 Completed - Switzerland ... More >> Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Spitaeler Chur AG Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Liestal, Switzerland, CH-4410 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 City Hospital Triemli Zurich, Switzerland, 8063 Klinik Hirslanden Zurich, Switzerland, CH-8008 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT00080340 Non Small Cell Lung Carcinoma Phase 3 Completed - -
NCT00252707 Non-Small Cell Lung Cancer Phase 3 Completed - Japan ... More >> Research Site Nagoya, Aichi, Japan Research Site Okazaki, Aichi, Japan Research Site Hirosaki, Aomori, Japan Research Site Kashiwa, Chiba, Japan Research Site Matsuyama, Ehime, Japan Research Site Asahikawa, Hokkaido, Japan Research Site Sapporo, Hokkaido, Japan Research Site Akashi, Hyogo, Japan Research Site Kobe, Hyogo, Japan Research Site Naka-gun, Ibaraki, Japan Research Site Isehara, Kanagawa, Japan Research Site Sagamihara, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Sendai, Miyagi, Japan Research Site Omura, Nagasaki, Japan Research Site Beppu, Oita, Japan Research Site Habikino, Osaka, Japan Research Site Izumisano, Osaka, Japan Research Site Osakasayama, Osaka, Japan Research Site Sakai, Osaka, Japan Research Site Toyonaka, Osaka, Japan Research Site Iwata, Shizuoka, Japan Research Site Sunto-gun, Shizuoka, Japan Research Site Bunkyo-ku, Tokyo, Japan Research Site Chuo, Tokyo, Japan Research Site Kiyose, Tokyo, Japan Research Site Minato-ku, Tokyo, Japan Research Site Shinjuku, Tokyo, Japan Research Site Sumida, Tokyo, Japan Research Site Toshima-ku, Tokyo, Japan Research Site Ube, Yamaguchi, Japan Research Site Fukuoka, Japan Research Site Gifu, Japan Research Site Kanazawa, Japan Research Site Kumamoto, Japan Research Site Nagasaki, Japan Research Site Niigata, Japan Research Site Okayama, Japan Research Site Osaka, Japan Research Site Yamagata, Japan Less <<
NCT00215202 Nonresectable Adrenocortical C... More >>arcinoma Less << Phase 2 Completed - United States, Kentucky ... More >> Kentuckiana Cancer Institute PLLC Louisville, Kentucky, United States, 40202 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, Texas The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00255489 Non-small-cell Lung Cancer Phase 1 Completed - United Kingdom ... More >> Research Site Edinburgh, United Kingdom Research Site Leeds, United Kingdom Less <<
NCT00479089 - Terminated(Study halted due to... More >> drug sponsor decision to not continue.) Less << - -
NCT00616499 Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Contact Person    82-2-2072-1742       Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joo-Hang Kim, MD    82-2-2228-8131    kjhang@yuhs.ac    Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Contact Person    82-2-3410-1247       Asan Medical Center - University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 138-736 Contact: Contact Person    82-2-3010-7282 Less <<
NCT00238251 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Completed - Switzerland ... More >> Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT00080743 Breast Cancer Phase 2 Completed - United States, New Hampshire ... More >> Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00256711 Non-Small-Cell Lung Carcinoma Phase 2 Completed - -
NCT00684385 Non Small Cell Lung Cancer|Can... More >>cer of the Head and Neck Less << APPROVED_FOR_MARKETING - Research Site, Berlin, 10117, ... More >>Germany|Research Site, Berlin, 13125, Germany|Research Site, Berlin, 13189, Germany|Research Site, Berlin, 14165, Germany|Research Site, Essen, 45122, Germany|Research Site, Frankfurt, 60590, Germany|Research Site, Freiburg, 79106, Germany|Research Site, Gro?hansdorf, 22927, Germany|Research Site, G?ttingen, 37075, Germany|Research Site, Halle, 06112, Germany|Research Site, Halle, 06120, Germany|Research Site, Heidelberg, 69126, Germany|Research Site, Kiel, 24105, Germany|Research Site, Laatzen, 30880, Germany|Research Site, Lemgo, 32657, Germany|Research Site, L?wenstein, 74245, Germany|Research Site, Mainz, 55131, Germany|Research Site, München, 81675, Germany|Research Site, Nürnberg, 90419, Germany|Research Site, Oldenburg, 26121, Germany|Research Site, Oldenburg, 26133, Germany|Research Site, Stralsund, 18437, Germany|Research Site, Stuttgart, 70174, Germany|Research Site, Trier, 54292, Germany|Research Site, Wiesbaden, 65199, Germany|Research Site, Budapest, 1121, Hungary|Research Site, Budapest, 1122, Hungary|Research Site, Budapest, 1125, Hungary|Research Site, Kecskemét, 6000, Hungary|Research Site, T?r?kbálint, 2045, Hungary|Research Site, Gdańsk, 80-952, Poland|Research Site, Warszawa, 02-781, Poland|Research Site, Zabrze, 41-803, Poland|Research Site, Newcastle-upon-Tyne, NE4 5BE, United Kingdom Less <<
NCT00298688 Small Cell Lung Cancer PHASE2 COMPLETED 2025-03-07 Research Site, Copenhagen, Den... More >>mark|Research Site, Herlev, Denmark|Research Site, Manchester, United Kingdom Less <<
NCT00132158 Glioblastoma ... More >>Rhabdomyosarcomas Neuroblastoma Osteosarcoma Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00479089 Bladder Cancer Phase 2 Terminated(Study halted due to... More >> drug sponsor decision to not continue.) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00023699 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT00502060 Advanced Tumor Phase 1 Completed - Netherlands ... More >> Research Site Amsterdam, Netherlands Research Site Nijmegen, Netherlands Research Site Utrecht, Netherlands Less <<
NCT00052754 Sarcoma Phase 2 Completed - Belgium ... More >> Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Bergonie Bordeaux, France, 33076 Centre Leon Berard Lyon, France, 69373 CHU de la Timone Marseille, France, 13385 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie - Section Medicale Paris, France, 75248 Institut Gustave Roussy Villejuif, France, F-94805 Netherlands Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Leiden University Medical Center Leiden, Netherlands, 2300 RC Nijmegen Cancer Center at Radboud University Medical Center Nijmegen, Netherlands, NL-6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE United Kingdom Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Royal Marsden NHS Foundation Trust - London London, England, United Kingdom, SW3 6JJ Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00057941 Estrogen Receptor-positive Bre... More >>ast Cancer Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00252811 Breast Cancer PHASE2 WITHDRAWN - Research Site, Milan, Italy
NCT00234403 Breast Cancer Phase 2 Completed - Spain ... More >> Investigative Site Alicante, Spain Investigative Site Gerona, Spain Investigative Site Jaen, Spain Investigative Site Madrid, Spain Investigative Site Seville, Spain Investigative Site Valencia, Spain Investigative Site Zaragoza, Spain Less <<
NCT00086957 Breast Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211-1850 City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Hematology Oncology Consultants-Hemet Hemet, California, United States, 92543 Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center Long Beach, California, United States, 90806 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT00076388 Non-Small-Cell Lung Carcinoma Phase 3 Completed - -
NCT00086957 - Completed - -
NCT00025675 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Neuro-Oncology Branch Bethesda, Maryland, United States, 20892-8200 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0316 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390-9154 M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00025350 Colorectal Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States, 60611 CCOP - Central Illinois Decatur, Illinois, United States, 62526 CCOP - Evanston Evanston, Illinois, United States, 60201 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Veterans Affairs Medical Center - New York New York, New York, United States, 10010 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 United States, North Dakota CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213-3489 United States, Tennessee Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus Nashville, Tennessee, United States, 37212 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 United States, Wisconsin Veterans Affairs Medical Center - Madison Madison, Wisconsin, United States, 53705 University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00238797 Glioblastoma PHASE2 COMPLETED 2025-03-06 Research Site, Link?ping, Swed... More >>en|Research Site, Stockholm, Sweden|Research Site, Ume?, Sweden Less <<
NCT00057941 - Completed - -
NCT00091156 Lung Cancer Phase 3 Terminated(low accrual) - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerpen, Belgium, B-2020 Ghent University Ghent, Belgium, B-9000 CHR - Clinique Saint Joseph - Hopital de Warqueguies Mons, Belgium, B-7000 Clinique Sainte Elisabeth Namur, Belgium, 5000 Cyprus Bank Of Cyprus Oncology Centre Nicosia, Cyprus, 2006 Strovolos Egypt National Cancer Institute of Egypt Cairo, Egypt Italy Ospedali Riuniti di Bergamo Bergamo, Italy, 24100 Ospedale Santa Croce Cuneo, Italy, 12100 Universita di Ferrara Ferrara, Italy, 44100 Presidio Ospedaliero di Livorno Livorno, Italy, 57100 Ospedale Luigi Sacco Milan, Italy, 20157 Ospedale Niguarda Ca'Granda Milan, Italy, 20162 Azienda Ospedaliera - Universitaria di Modena Modena, Italy, 41100 Azienda Ospedaliera Maggiore Della Carita Novara, Italy, 28100 Azienda Ospedale S. Luigi at University of Torino Orbassano, Italy, 10043 Azienda Ospedaliera Policlinico Paolo Giaccone Palermo, Italy, 90127 Azienda Ospedaliera Di Parma Parma, Italy, 43100 Azienda Ospedaliera "Santa Maria Degli Angeli" Pordenone, Italy, 33170 Ospedale Sta. Maria Delle Croci Ravenna, Italy, 48100 Arcispedale S. Maria Nuova Reggio Emilia, Italy, 42100 Azienda Ospedaliera S. Camillo-Forlanini Rome, Italy, 00152 Ospedale di Circolo e Fondazione Macchi Varese, Italy, 21100 Ospedale Civile Maggiore - Borgo Trento Verona, Italy, 37126 Netherlands Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands, 5211 NL Rijnstate Hospital Arnhem, Netherlands, 6800 TA Kennemer Gasthuis - Locatie EG Haarlem, Netherlands, 2000 Leiden University Medical Center Leiden, Netherlands, 2300 RC St. Franciscus Gasthuis Rotterdam, Netherlands, 3045 PM Less <<
NCT02847377 Carcinoma, Non-Small-Cell Lung Early Phase 1 Recruiting March 27, 2019 France ... More >> CGFL Recruiting Dijon, France, 21079 Less <<
NCT00418080 Prostate Cancer Phase 2 Completed - Italy ... More >> University of L'Aquila L'Aquila, Abruzzo, Italy, 67100 Less <<
NCT01854034 - Completed - -
NCT01854034 Non Small Cell Lung Cancer Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02350361 Lung Cancer Phase 2 Phase 3 Unknown March 2016 China ... More >> Peking University Third Hospital Recruiting Beijing, China Contact: Li Liang, MD    13241870816 Less <<
NCT01480141 Lung Cancer Phase 2 Withdrawn(PI left MUSC, no pat... More >>ient enrollments) Less << - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT03399487 Non-small Cell Lung Cancer Har... More >>boring ROS1 Rearrangement Less << Phase 2 Not yet recruiting October 2020 -
NCT02759835 Lung Adenocarcinoma ... More >> Lung Neoplasms Less << Phase 2 Recruiting September 1, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00716456 Lung Adenocarcinoma Phase 1 Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT00124280 Non-small-cell Lung Carcinoma Phase 2 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, Texas MD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology Houston, Texas, United States, 77030 Less <<
NCT02716311 Non Small Cell Lung Cancer Phase 2 Recruiting January 2020 France ... More >> Centre Hospitalier du Pays d'Aix Not yet recruiting Aix-en-Provence, France Contact: Stéphanie MARTINEZ       contact@ifct.fr    Clinique de L'Europe Not yet recruiting Amiens, France Contact: Olivier CARRE, Dr          Angers - CHU Recruiting Angers, France Contact: José Hureaux, Dr          Principal Investigator: José Hureaux, Dr          Annecy - CH Recruiting Annecy, France, 74374 Contact: Chantal DECROISETTE, Dr          Bordeaux - Institut Bergonié Not yet recruiting Bordeaux, France Contact: Sylvestre LE MOULEC, Dr       contact@ifct.fr    Principal Investigator: LE MOULEC Sylvestre, Dr          Bordeaux - Polyclinique Nord Recruiting Bordeaux, France Contact: Nadine DOHOLLOU, Dr       contact@ifct.fr    Principal Investigator: Nadine DOHOLLOU, Dr          Boulogne - Ambroise Paré Recruiting Boulogne-Billancourt, France Contact: Etienne GIROUX-LEPRIEUR, MD          Principal Investigator: Etienne GIROUX-LEPRIEUR, MD          Clermont-Ferrand - CHU Not yet recruiting Clermont-Ferrand, France Contact: Patrick MERLE, MD          Principal Investigator: Patrick MERLE, MD          CH Recruiting Colmar, France Contact: Lionel MOREAU       contact@ifct.fr    CHRU Grenoble Recruiting Grenoble, France Contact: Denis MORO-SIBILOT       contact@ifct.fr    Centre Hospitalier - Pneumologie Recruiting Le Mans, France, 72000 Contact: Olivier Molinier, Dr          CHRU de Lille Recruiting Lille, France Contact: Alexis CORTOT, Pr       contact@ifct.fr    Lille - Polyclinique de la Louvière Not yet recruiting Lille, France Contact: Benjamin HURET, Dr       contact@ifct.fr    Principal Investigator: Benjamin HURET, Dr          Lyon - Hôpital Privé Jean Mermoz Not yet recruiting Lyon, France Contact: Pierre Bombaron, MD       contact@ifct.fr    Principal Investigator: Pierre BOMBARON, MD          Institut Paoli Calmette Recruiting Marseille, France Contact: Anne MADROSZYK, Dr          Montpellier - GCS Centre de Cancérologie du Grand Montpellier Not yet recruiting Montpellier, France Contact: Catherine Becht, Dr          Principal Investigator: Catherine Becht, Dr          CH de Mulhouse Recruiting Mulhouse, France Contact: Didier DEBIEUVRE       contact@ifct.fr    Nantes - ICO René Gauducheau Recruiting Nantes, France Contact: Judith RAIMBOURG, Dr       contact@ifct.fr    Principal Investigator: Judith RAIMBOURG, Dr          Nevers - CH Not yet recruiting Nevers, France, 58033 Contact: Dominique Herman, Dr          Centre Antoine Lacassagne Recruiting Nice, France Contact: Josiane OTTO, MD       contact@ifct.fr    Orléans - Hôpital de la Source Recruiting Orléans, France Contact: Hugues MOREL, Dr       contact@ifct.fr    Principal Investigator: Hugues MOREL, Dr          AP-HP Hopital Tenon - Pneumologie Recruiting Paris, France, 75020 Contact: Jacques Cadranel, Pr    +33.1.56.01.65.31    contact@ifct.fr    Principal Investigator: Jacques Cadranel, pr          Paris - APHP Bichat Not yet recruiting Paris, France Contact: Valérie Gounant, Dr       contact@ifct.fr    Principal Investigator: Valérie Gounant, Dr          Paris - APHP Saint-Louis Recruiting Paris, France Contact: Ludovic DOUCET, MD       contact@ifct.fr    Principal Investigator: Ludovic DOUCET, MD          Pau - CH Recruiting Pau, France, 64046 Contact: Aldo RENAULT, Dr       contact@ifct.fr    Pontoise - CH Not yet recruiting Pontoise, France Contact: Cécile DURAND-MATRINGE, MD       contact@ifct.fr    Principal Investigator: Cécile DURAND-MATRINGE, MD          Centre Hospitalier Recruiting Saint-Quentin, France Contact: Isabelle RAULT, MD       contact@ifct.fr    Nouvel Hopital Civil - Pneumologie Recruiting Strasbourg, France, 63000 Contact: Charlotte Leduc, Dr          Principal Investigator: Charlotte Leduc, Dr          Centre Hospitalier Intercommunal Recruiting Toulon, France Contact: Clarisse AUDIGIER-VALETTE, Dr          HIA Saint Anne Recruiting Toulon, France Contact: Henri BERARD, Dr       contact@ifct.fr    Tours - CHU Not yet recruiting Tours, France, 37000 Contact: Eric Pichon, Dr       contact@ifct.fr    CH de Villefranche - Pneumologie Recruiting Villefranche, France Contact: Luc ODIER       contact@ifct.fr    Principal Investigator: Luc ODIER          Villeneuve d'Ascq - Hôpital Privé Not yet recruiting Villeneuve-d'Ascq, France Contact: Benjamin HURET, MD          Principal Investigator: Benjamin HURET, MD Less <<
NCT02723578 Metastatic Colorectal Cancer Phase 2 Active, not recruiting November 2018 Korea, Republic of ... More >> Yonsei University Health System, Severance Hospital Seoul, Korea, Republic of, 03722 Less <<
NCT00579683 - Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT00716456 - Completed - -
NCT03151161 Lung, Carcinoma Phase 2 Not yet recruiting May 2019 China, Guangdong ... More >> Recruiting Guanzhou, Guangdong, China, 510000 Contact: Long Hao, Prof    +86 2087343261    longhao@sysucc.org.cn    Contact: Ruping Xing    +86 2087343736    xingrp@sysucc.org.cn Less <<
NCT00051051 Breast Neoplasms Phase 2 Completed - -
NCT02191059 Non Small Cell Lung Cancer Phase 2 Unknown July 2016 China, Shandong ... More >> Shandong Cancer Hospital and Institute Not yet recruiting Jinan, Shandong, China, 250117 Contact: Zhehai Wang, MD    0086-531-67626331    wzhai8778@sina.com    Principal Investigator: Zhehai Wang, MD Less <<
NCT02066038 Lung, Carcinoma Phase 2 Unknown March 2016 -
NCT01449201 Head Neck Cancer Squamous Cell... More >> Metastatic Head Neck Cancer Squamous Cell Recurrent Less << Phase 2 Completed - Korea, Republic of ... More >> Chilgok Kyungpook National University Hospital Daegu, Korea, Republic of Dongsan Medical Center Daegu, Korea, Republic of Severance Hospital Seoul, Korea, Republic of, 120-752 Asan Medical Center Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Cancer Center Seoul, Korea, Republic of Less <<
NCT01209650 - - - Australia, New South Wales ... More >> 1200.47.1 Boehringer Ingelheim Investigational Site North Ryde, New South Wales, Australia Less <<
NCT00615758 Non Small Cell Lung Cancer Phase 2 Completed - Greece ... More >> 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Sotiria" General Hospital, 2nd Dep of Pulmonary Diseases Athens, Greece "Diabalkaniko" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT03424759 Non Small Cell Lung Cancer Phase 2 Active, not recruiting July 31, 2019 Korea, Republic of ... More >> Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Less <<
NCT00999804 Breast Cancer Phase 2 Active, not recruiting January 2018 United States, Alabama ... More >> University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02130 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37212 United States, Texas Baylor College of Medicine Lester and Sue Smith Breast Center Houston, Texas, United States, 77030 Less <<
NCT00999804 - Active, not recruiting - -
NCT03680183 - Recruiting December 31, 2021 China, Guangdong ... More >> Affiliated Cancer Hospital & Institute of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510182 Contact: Wenying Shu, PhD    86-20-66673666 ext 2006    790840799@qq.com    Contact: Tiantian Cheng, MD    86-20-66673677    gyzlgcp@163.com Less <<
NCT01880515 Skin Rash Lun... More >>g Cancer Less << Phase 2 Completed - Mexico ... More >> Instituto Nacional de Cancerología México, D.F., Mexico city, Mexico, 14080 Less <<
NCT03090815 - Recruiting December 2017 Hong Kong ... More >> University of Hong Kong Queen Mary Hospital Recruiting Hong Kong, Hong Kong, 0 Contact: David CL Lam, BSc,MBBS,PhD,FCCP,FACP,FRCP(E)    (852) 2255 5814    dcllam@hku.hk    Principal Investigator: David CL Lam, BSc,MBBS,PhD,FCCP,FACP,FRCP(E) Less <<
NCT01880515 - Completed - -
NCT03486509 Squamous Cell Carcinoma Phase 2 Not yet recruiting July 1, 2020 -
NCT02323516 Cancer Phase 2 Withdrawn - France ... More >> CHU Amiens, France Centre François Baclesse Caen, France, 14076 Centre Hospitalier public du Cotentin Cherbourg, France, 50100 Centre hospitalier Compiegne, France Centre Léon Bérard Lyon, France Less <<
NCT02353936 Squamous Cell Carcinoma of Eso... More >>phagus Less << Phase 2 Recruiting January 2019 Korea, Republic of ... More >> Severance hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Hye Ryun Kim, MD    82-2-2228-8125    nobelg@yuhs.ac Less <<
NCT02755337 - Unknown December 2016 Indonesia ... More >> Dr. Soetomo General Hospital Recruiting Surabaya, East Java, Indonesia, 60286 Contact: Laksmi Wulandari, MD. PhD    +628123019591    laksmigts@yahoo.co.id    Principal Investigator: Laksmi Wulandari, MD, PhD Less <<
NCT01163058 - Unknown July 2011 Italy ... More >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20059 Less <<
NCT02139579 Lung, Carcinoma Phase 2 Unknown - -
NCT02778893 NSCLC Phase 4 Recruiting March 2020 China, Henan ... More >> XZhang Recruiting Zhengzhou, Henan, China, 450000 Contact: zhang xiaoju    15837101166       Principal Investigator: zhang xiaoju Less <<
NCT01193829 - Unknown December 2014 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore Contact: Ross Andrew Soo, MBBS    65-6772-4624    Ross_Soo@nuh.com.sg    Principal Investigator: Ross Andrew Soo, MBBS Less <<
NCT02906163 EGFR Mutation Positive Non Sma... More >>ll Cell Lung Cancer Less << Phase 1 Phase 2 Not yet recruiting January 2020 Italy ... More >> Azienda Sanitaria Locale Frosinone Not yet recruiting Frosinone, Italy Contact: Dott.ssa Teresa Gamucci          Principal Investigator: Dott.ssa Teresa Gamucci          Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Dott.ssa Marina Chiara Garassino          Principal Investigator: Dott.ssa Marina Chiara Garassino          Roma_Campus Bio-Medico Not yet recruiting Rome, Italy Contact: Prof. Daniele Santini          Principal Investigator: Prof. Daniele Santini          Sant'Andrea Hospital Not yet recruiting Rome, Italy Contact: Prof. Paolo Marchetti          Principal Investigator: Prof. Paolo Marchetti          Presidio Sanitario San Camillo Not yet recruiting Torino, Italy Contact: Dott.ssa Maria Rita Migliorino          Principal Investigator: Dott.ssa Maria Rita Migliorino Less <<
NCT03239015 Rare Tumor Re... More >>fractory Tumor Less << Phase 2 Recruiting December 31, 2019 China, Shanghai ... More >> Shanghai Changzheng Hospital Recruiting Shanghai, Shanghai, China, 200003 Contact: Xiao-Dong Jiao, MD    +86-13817797639    pulava@139.com Less <<
NCT02157883 - Active, not recruiting - -
NCT01580735 Non-small-cell Lung Cancer Phase 2 Completed - Japan ... More >> Arakawa-ku, Tokyo, Japan Less <<
NCT00266877 Carcinoma, Non-Small-Cell Lung... More >> Lung Neoplasms Less << Phase 2 Completed - United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Illinois Midwestern Regional Medical Center Zion, Illinois, United States, 60099 United States, Massachusetts Massachusetts General Hospital, Yawkey Center for Outpatient Care Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Memorial Sloan-Kettering New York, New York, United States, 10021 United States, North Carolina Carolinas Hematology-Oncology Associates Charlotte, North Carolina, United States, 28203 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-6868 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 France Institut Gustave Roussy Villejuif, France, 94805 Hungary Országos Korányi TBC és Pulmonológiai Intézet Budapest, Hungary, H-1529 University of Debrecen Debrecen, Hungary, H-4012 Poland Akademia Medyczna W Gdansku Gdansk, Poland, 80-952 Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy Otwock, Poland, 05-400 Wielkopolskie Centrum Chorób Płuc i Gruźlicy Poznan, Poland, 60-569 Dolnośląskie Centrum Chorób Płuc we Wrocławiu Wrocław, Poland, 54-439 Spain Hospital Germans Trias I Puyol Badalona, Barcelona, Spain, 08916 Less <<
NCT01963195 NSCLC Phase 2 Recruiting December 2019 China, Anhui ... More >> Dept. of Oncology,The First Affiliated Hospital of Anhui Medical Univesrsity Recruiting Hefei, Anhui, China, 230032 Contact: Hu Liu, MD    865512922987    drliuhu@gmail.com    Principal Investigator: Yueyin Pan, MD Less <<
NCT02745691 - Recruiting December 31, 2018 Germany ... More >> Center for Clinical Studies, University Hospital Regensburg Recruiting Regensburg, Germany Contact: Koller       michael.koller@klinik.uni-regensburg.de Less <<
NCT02157883 Advanced Non Small Cell Lung C... More >>ancer Advanced (Inoperable) Non Small Cell Lung Cancer Less << Phase 1 Active, not recruiting December 31, 2018 United States, California ... More >> Research Site San Diego, California, United States, 92123 United States, Ohio Research Site Cleveland, Ohio, United States, 44106-4950 Belgium Research Site Edegem, Belgium, 2650 Research Site Gent, Belgium, 9000 Korea, Republic of Research Site Seongnam-si, Korea, Republic of, 13620 Research Site Seoul, Korea, Republic of, 03080 Research Site Seoul, Korea, Republic of, 03722 Research Site Seoul, Korea, Republic of, 06351 Research Site Seoul, Korea, Republic of, 138-736 Netherlands Research Site Amsterdam, Netherlands, 1066 CX Research Site Maastricht, Netherlands, 6229 HX Research Site Rotterdam, Netherlands, 3015 CE Taiwan Research Site Taipei, Taiwan, 10002 Research Site Taipei, Taiwan, 11217 United Kingdom Research Site London, United Kingdom, SE1 9RT Research Site Manchester, United Kingdom, M20 4BX Less <<
NCT00553254 Carcinoma, Non Small Cell Lung Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Pfizer Investigational Site Seoul, Korea, Republic of, 135-710 Less <<
NCT03595644 Stage IV Non-small Cell Lung C... More >>ancer Less << Phase 2 Not yet recruiting October 10, 2021 China, Hubei ... More >> Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: li Zhang, PhD Less <<
NCT02039674 - Active, not recruiting - -
NCT01619618 - Completed - -
NCT00266877 - Completed - -
NCT01697163 - Unknown September 2014 -
NCT02859077 Non-Small-Cell Lung Cancer Phase 3 Unknown July 2018 -
NCT01192230 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown - China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Chang, MD,PhD    13916619284    changjianhua@hotmail.com Less <<
NCT03119519 Stage IV Non-small Cell Lung C... More >>ancer Less << Phase 2 Recruiting September 2021 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Xiaoxia Zhu, M.D.    +862062787696    zhuxx01@126.com Less <<
NCT02013089 Gastrointestinal Cancers Not Applicable Unknown December 2017 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD    008613925106525    13925106525@163.com    Principal Investigator: Yanhong Deng, PhD Less <<
NCT02039674 Non-small Cell Lung Carcinoma Phase 1 Phase 2 Active, not recruiting October 18, 2021 United States, California ... More >> Call for Information (Investigational Site 0018) La Jolla, California, United States, 92037 Call for Information (Investigational Site 0010) San Francisco, California, United States, 94115 United States, Indiana Call for Information (Investigational Site 0019) Indianapolis, Indiana, United States, 46202 United States, Massachusetts Call for Information (Investigational Site 0017) Boston, Massachusetts, United States, 02114 Call for Information (Investigational Site 0002) Boston, Massachusetts, United States, 02215 Call for Information (Investigational Site 0016) Boston, Massachusetts, United States, 02215 United States, Nebraska Call for Information (Investigational Site 0023) Omaha, Nebraska, United States, 68130 United States, New Jersey Call for Information (Investigational Site 0055) Hackensack, New Jersey, United States, 07601 United States, New York Call for Information (Investigational Site 0056) Lake Success, New York, United States, 11042 United States, Pennsylvania Call for Information (Investigational Site 0009) Philadelphia, Pennsylvania, United States, 19104 Call for Information (Investigational Site 0015) Philadelphia, Pennsylvania, United States, 19104 Call for Information (Investigational Site 0004) Philadelphia, Pennsylvania, United States, 19111 United States, Texas Call for Information (Investigational Site 0007) Houston, Texas, United States, 77030 Call for Information (Investigational Site 0003) San Antonio, Texas, United States, 78229 Taiwan Merck Sharp & Dohme (I.A.) Corp. Taipei, Taiwan Less <<
NCT00198393 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - France ... More >> CHU Avicenne - Oncologie Bobigny, France, 93000 CHU Grenoble - pneumologie Grenoble, France, 38000 Less <<
NCT03382795 EGFR Positive Non-small Cell L... More >>ung Cancer Less << Phase 2 Recruiting September 30, 2021 Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Recruiting Anyang, Gyeonggi-do, Korea, Republic of, 14068 Contact: Seung Hun Jang, MD, Ph.D.          Principal Investigator: Seung Hun Jang, MD, Ph.D.          Pusan National University Yangsan Hospital Recruiting Yangsan, Gyeongsangnam-do, Korea, Republic of, 50612 Contact: Seong Hoon Yoon, MD, Ph.D.          Principal Investigator: Seong Hoon Yoon, MD, Ph.D.          Sub-Investigator: YUN SEONG KIM, MD, Ph.D.          Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeollanam-do, Korea, Republic of, 58128 Contact: In Jae Oh, MD, Ph.D.          Principal Investigator: In Jae Oh, MD, Ph.D.          Sub-Investigator: Young Chul Kim, MD, Ph.D.          Sub-Investigator: Chul Kyu Park, MD          Chungnam National University Hospital Recruiting Daejeon, Korea, Republic of, 35015 Contact: Jeong Eun Lee, MD, Ph.D.          Principal Investigator: Jeong Eun Lee, MD, Ph.D.          Sub-Investigator: Chaeuk Chung, MD, Ph.D.          Sub-Investigator: Dong Il Park, MD          Yonsei University Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Contact: Eun Young Kim, MD, Ph.D.          Principal Investigator: Eun Young Kim, MD, Ph.D.          Sub-Investigator: Jeong Mo Lee, MD          Konkuk University Medical Center Recruiting Seoul, Korea, Republic of, 05030 Contact: Kye Young Lee, MD, Ph.D.          Principal Investigator: Kye Young Lee, MD, Ph.D.          Sub-Investigator: Hee Joung Kim, MD, Ph.D.          Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact: Jae Cheol Lee, MD, Ph.D.          Principal Investigator: Jae Cheol Lee, MD, Ph.D.          Sub-Investigator: Chang-Min Choi, MD, Ph.D.          Korea University Guro Hospital Recruiting Seoul, Korea, Republic of, 08308 Contact: Seung-hoe Song, MBE    82-2-2626-1635    ssessong@korea.ac.kr    Principal Investigator: Sung Yong Lee, MD, Ph.D.          Sub-Investigator: Jee Youn Oh, MD Less <<
NCT01556191 Stage IV Lung Cancer Phase 2 Active, not recruiting December 2018 -
NCT03461185 Non Small Cell Lung Cancer Phase 2 Not yet recruiting February 20, 2020 China, Chongqing ... More >> XinQiao Hospital Not yet recruiting Chongqing, Chongqing, China, 400037 Contact: cheng zheng tang, professor    023-68755114 ext UK    wangjm1987@foxmail.com    Principal Investigator: ZhengTang Chen, professor Less <<
NCT02787447 Lung Adenocarcinoma Phase 2 Recruiting May 2020 China, Zhejiang ... More >> Hangzhou First People's Hospital Recruiting Hangzhou, Zhejiang, China, 310006 Contact: Shirong Zhang, Dr.    086057156007650    shirley4444@gmail.com Less <<
NCT02882984 Stage IV EGFR Mutated NSCL Wit... More >>h Brain Metastases Less << Phase 3 Recruiting December 2020 China, Sichuan ... More >> Sichuan PPH, Cancer Center Recruiting Chengdu, Sichuan, China, 710062 Contact: Yifeng Bai, MD PhD    18183298718    15756285949@qq.com    Contact: Ming zeng, MD PhD    008617708131336    miller2002@yahoo.com Less <<
NCT01776684 EGFR Mutation Positive Non-sma... More >>ll Cell Lung Cancer Less << Not Applicable Unknown May 2015 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, M.D., Ph.D.       silkahn@skku.edu Less <<
NCT03333343 EGFR-mutant Non-small Cell Lun... More >>g Cancer Less << Phase 1 Recruiting May 21, 2021 Canada, Ontario ... More >> Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Germany Novartis Investigative Site Recruiting Koeln, Germany, 50937 Italy Novartis Investigative Site Recruiting Ancona, AN, Italy, 60126 Novartis Investigative Site Recruiting Milano, MI, Italy, 20162 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Taiwan Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Less <<
NCT01121575 - Completed - -
NCT00005806 Lung Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00135135 Neuroblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01745302 - Unknown December 2016 -
NCT03389256 Lung Diseases ... More >> Neoplasms Respiratory Tract Diseases Thoracic Neoplasms Non-Small-Cell Lung Less << Phase 2 Not yet recruiting August 30, 2022 China, Sichuan ... More >> Sichuan Cancer Hospital Chengdu, Sichuan, China, 610041 West China Hospital, Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610041 Contact: Panwen Tian, MD    +8618036675920       Sichuan Provincial People's Hospital Not yet recruiting Chengdu, Sichuan, China, 610071 Contact: Rui Ao, MD    +8618036675290    aorui1040@hotmail.com Less <<
NCT00955695 Lung Cancer Phase 3 Unknown - -
NCT01861223 NSCLC Phase 1 Phase 2 Unknown May 2016 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Myung-Ju Ahn          Sub-Investigator: Jong-Mu Sun Less <<
NCT01121575 Non Small Cell Lung Cancer Phase 1 Completed - United States, Colorado ... More >> Clinical Trials Office University of Colorado Hospital (CTO) Aurora, Colorado, United States, 80045 DRUG SHIPMENT: University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Rocky Mountain Lions Eye Institute Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Maryland CCR, National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Massachusetts Drug Shipment Only Boston, Massachusetts, United States, 02114 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Drug Shipment Only Boston, Massachusetts, United States, 02215 Australia, Victoria Peter MacCallum Cancer Centre, Division of Haematology and Medical Oncology East Melbourne, Victoria, Australia, 3002 Less <<
NCT02714010 Non-Small Cell Lung Cancer Phase 3 Recruiting December 2022 China, Guangdong ... More >> Sun Yat-sen University of cancer center Recruiting Guangzhou, Guangdong, China, 510000 Contact: li-kun chen, doctor    13798019964 Less <<
NCT01090011 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - United States, Colorado ... More >> 1200.71.1004 Boehringer Ingelheim Investigational Site Aurora, Colorado, United States United States, Connecticut 1200.71.1003 Boehringer Ingelheim Investigational Site New Haven, Connecticut, United States United States, New York 1200.71.1001 Boehringer Ingelheim Investigational Site New York, New York, United States United States, Tennessee 1200.71.1002 Boehringer Ingelheim Investigational Site Nashville, Tennessee, United States Netherlands 1200.71.2002 Boehringer Ingelheim Investigational Site Amsterdam, Netherlands 1200.71.2001 Boehringer Ingelheim Investigational Site Groningen, Netherlands Less <<
NCT02411448 Metastatic Non-Small Cell Lung... More >> Cancer Less << Phase 3 Active, not recruiting September 1, 2022 -
NCT02889692 Cancer Phase 3 Unknown December 2016 -
NCT02031601 Non-Small-Cell Lung Cancer Phase 4 Unknown December 2017 China, Shandong ... More >> Yu Li Recruiting Jinan, Shandong, China, 250012 Contact: Yu Li Less <<
NCT00280787 Non Small Cell Lung Cancer Phase 2 Completed - United States, North Carolina ... More >> University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01090011 - Completed - -
NCT02740894 Is Targeted Therapy Increasing... More >> Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ? Less << COMPLETED 2025-04-16 -
NCT03766490 Non-Small-Cell Lung Not Applicable Not yet recruiting December 20, 2020 China, Jangsu ... More >> The First Affiliated hospital of soochow university Not yet recruiting Suzhou, Jangsu, China Contact: Min Tao, Doctor Less <<
NCT00193596 Neoplasms, Unknown Primary Phase 3 Completed - -
NCT02321293 Lung Cancer Phase 1 Unknown December 2016 Canada, Quebec ... More >> Peter Brojge Lung Cancer Center, Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Victor Cohen, MD,CM, FRCPC    514-340-8222 ext 3878    vcohen@jgh.mcgill.ca    Contact: Goulnar Kasymjanova, MD    514-340-8222 ext 4312    gkasymja@jgh.mcgill.ca    Sub-Investigator: Khashayar Esfahani, MD          Sub-Investigator: Arif Awan, MD          Sub-Investigator: Thomas R Jagoe, MD          Sub-Investigator: Jason S Agulnik, MD          Sub-Investigator: David Small, MD          Sub-Investigator: Carmela Pepe, MD          Sub-Investigator: Lama Sakr, MD          Sub-Investigator: Goulnar Kasymjanova, MD Less <<
NCT02788058 Lung Adenocarcinoma ... More >> EGFR Positive Non-small Cell Lung Cancer Less << Phase 2 Not yet recruiting May 2022 -
NCT01784549 Non Small Cell Lung Cancer Phase 2 Unknown December 2015 Italy ... More >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genoa, Italy, 16132 Contact: Francesco Grossi, MD    +393355255484    fg1965@libero.it Less <<
NCT01448187 - Completed - France ... More >> Research Site Aulnay Sous Bois, France Research Site Bayonne, France Research Site Bordeaux, France Research Site Bron, France Research Site Carcassonne, France Research Site Chalon Sur Saone, France Research Site Cholet, France Research Site Clamart, France Research Site Colmar, France Research Site Corbeil Essonnes, France Research Site Creteil, France Research Site Epernay, France Research Site La Source, France Research Site Macon, France Research Site Marseille, France Reseacrh Site Metz, France Research Site Mont de Marsan, France Research Site Niort, France Research Site Paris, France Research Site Pierre Benite, France Research Site Quimper, France Research Site Reims, France Research Site Rouen, France Research Site St Herblain, France Research Site St Nazaire, France Research Site St Omer, France Research Site Strasbourg, France Research Site Toulon, France Research Site Vienne, France Less <<
NCT00193596 - Completed - -
NCT03050411 Nonsmall Cell Lung Cancer Phase 1 Recruiting October 2019 China, Beijing ... More >> Peking University Third Hospital Recruiting Beijing, Beijing, China Contact: Li Liang, MD    13241870816 Less <<
NCT03002844 Nonsmall Cell Lung Cancer ... More >> EGFR Gene Mutation Less << Phase 2 Unknown December 2018 -
NCT01602289 Solid Tumors ... More >>Lymphoma Carcinoma, Non-Small-Cell Lung Less << Phase 1 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277-8577 Less <<
NCT02416739 Non-Small-Cell Lung Carcinoma Phase 2 Phase 3 Active, not recruiting June 2020 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Chonnam, Korea, Republic of, 58128 Less <<
NCT02893332 Stage IV EGFR Mutated Non-Smal... More >>l Cell Lung Cancer Less << Phase 3 Recruiting December 2020 China, Sichuan ... More >> Sichuan PPH, Cancer Center Recruiting Chengdu, Sichuan, China, 710062 Contact: Ming Zeng, MD PhD    008617708131336    miller2002@yahoo.com    Contact: Ruilian Yu, MD    008617708130619    19986720@qq.com Less <<
NCT03720873 EGFR Gene Mutation Phase 2 Recruiting September 2022 China, Fujian ... More >> Fujian cancer hospital Recruiting Fuzhou, Fujian, China Contact: Zhiyong He, master    0086-591-83660063 Less <<
NCT00993499 - Completed - -
NCT01085136 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT03170180 Stomach Neoplasms Phase 2 Recruiting October 31, 2020 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Sung Ju Park    234106820       Principal Investigator: Jeeyun Lee, M.D., Ph.D. Less <<
NCT01085136 - Completed - -
NCT00711594 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - Japan ... More >> 1200.33.010 Boehringer Ingelheim Investigational Site Akashi, Hyogo, Japan 1200.33.001 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan 1200.33.007 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1200.33.013 Boehringer Ingelheim Investigational Site Hidaka, Saitama, Japan 1200.33.011 Boehringer Ingelheim Investigational Site Kanazawa, Ishikawa, Japan 1200.33.003 Boehringer Ingelheim Investigational Site Kashiwa, Chiba, Japan 1200.33.019 Boehringer Ingelheim Investigational Site Kobe, Hyogo, Japan 1200.33.008 Boehringer Ingelheim Investigational Site Koto-ku, Tokyo, Japan 1200.33.020 Boehringer Ingelheim Investigational Site Matsuyama, Ehime, Japan 1200.33.006 Boehringer Ingelheim Investigational Site Miyakojima-ku, Osaka, Japan 1200.33.004 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1200.33.017 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1200.33.016 Boehringer Ingelheim Investigational Site Niigata, Niigata, Japan 1200.33.009 Boehringer Ingelheim Investigational Site Okayama, Okayama, Japan 1200.33.005 Boehringer Ingelheim Investigational Site Osaka-Sayama, Osaka, Japan 1200.33.018 Boehringer Ingelheim Investigational Site Sakai, Osaka, Japan 1200.33.015 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1200.33.012 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1200.33.002 Boehringer Ingelheim Investigational Site Sunto-gun, Shizuoka, Japan 1200.33.014 Boehringer Ingelheim Investigational Site Yufu, Oita, Japan Less <<
NCT00252759 - Completed - Japan ... More >> Research Site Nagoya, Aichi, Japan Research Site Okazaki, Aichi, Japan Research Site Toyoake, Aichi, Japan Research Site Imba-gun, Chiba, Japan Research Site Kashiwa, Chiba, Japan Research Site Matsuyama, Ehime, Japan Research Site Kitakyushu, Fukuoka, Japan Research Site Asahikawa, Hokkaido, Japan Research Site Sapporo, Hokkaido, Japan Research Site Akashi, Hyogo, Japan Research Site Kobe, Hyogo, Japan Research Site Kanazawa, Ishikawa, Japan Research Site Isehara, Kanagawa, Japan Research Site Sagamihara, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Sendai, Miyagi, Japan Research Site Omura, Nagasaki, Japan Research Site Tenri, Nara, Japan Research Site Ginowan, Okinawa, Japan Research Site Habikino, Osaka, Japan Research Site Izumisano, Osaka, Japan Research Site Osakasayama, Osaka, Japan Research Site Sakai, Osaka, Japan Research Site Toyonaka, Osaka, Japan Research Site Tokyo, Ota, Japan Research Site Otsu, Shiga, Japan Research Site Sunto-gun, Shizuoka, Japan Research Site Bunkyo-ku, Tokyo, Japan Research Site Bunkyo, Tokyo, Japan Research Site Kiyose, Tokyo, Japan Research Site Minato-ku, Tokyo, Japan Research Site Mitaka, Tokyo, Japan Research Site Shinjuku, Tokyo, Japan Research Site Toshima-ku, Tokyo, Japan Research Site Fukuoka, Japan Research Site Gifu, Japan Research Site Hiroshima, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Nagasaki, Japan Research Site Niigata, Japan Research Site Okayama, Japan Research Site Osaka, Japan Research Site Toyama, Japan Less <<
NCT00233623 Metastatic Colorectal Cancer Phase 2 Withdrawn January 2006 Italy ... More >> Research Center Bari, Italy Research Site Bergamo, Italy Research Site Catania, Italy Research Site Cremona, Italy Research Site Cuneo, Italy Research Site L'Aquila, Italy Research Site La Spezia, Italy Research Site Milano, Italy Research Site Palermo, Italy Research Site Pescara, Italy Research Site Rozzano, Italy Research Site Torino, Italy Research Site Venezia, Italy Less <<
NCT00711594 - Completed - -
NCT00993499 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - Spain ... More >> 1200.70.34001 Boehringer Ingelheim Investigational Site Badalona (Barcelona), Spain 1200.70.34008 Boehringer Ingelheim Investigational Site Barcelona, Spain 1200.70.34009 Boehringer Ingelheim Investigational Site Barcelona, Spain 1200.70.34006 Boehringer Ingelheim Investigational Site Girona, Spain 1200.70.34007 Boehringer Ingelheim Investigational Site L'Hospitalet de Llobregat (Barcelona), Spain 1200.70.34005 Boehringer Ingelheim Investigational Site Majadahonda (Madrid), Spain 1200.70.34004 Boehringer Ingelheim Investigational Site Valencia, Spain 1200.70.34002 Boehringer Ingelheim Investigational Site Zaragoza, Spain Less <<
NCT02804100 - Unknown June 2018 China, Zhejiang ... More >> Wenzhou Medical University Recruiting Wenzhou, Zhejiang, China, 325000 Contact: Ju Luan, PhD       luanluanjuju@163.com    Contact: Wenfeng Li, MD Less <<
NCT00242762 Head and Neck Cancer Phase 2 Completed - Spain ... More >> Research Facility Granada, Spain Research Facility Madrid, Spain Research Facility Murcia, Spain Research Site Sevilla, Spain Less <<
NCT03123484 Non Small Cell Lung Cancer Phase 2 Not yet recruiting October 2019 -
NCT00189358 Ovarian Cancer ... More >> Cancer of the Fallopian Tube Peritoneal Cancer Less << Phase 2 Completed - Germany ... More >> Dept. of Gynecology, Evangelisches Krankenhaus Duesseldorf, Germany, 40217 Less <<
NCT01746277 Non Small Cell Lung Cancer Phase 2 Unknown June 2016 China ... More >> Department of Respiratory Medicne, Peking Union Medical Hospital Recruiting Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206    zhaojing0@163.com    Sub-Investigator: Wei Zhong, MD Less <<
NCT00333294 Non-Small Cell Lung Cancer Phase 2 Completed - France ... More >> Research Site Clermont Ferrand, France Research Site Grenoble, France Research Site Nantes, France Research SIte Paris, France Less <<
NCT00006049 Lung Cancer Phase 3 Unknown - United States, Delaware ... More >> AstraZeneca Pharmaceuticals LP Wilmington, Delaware, United States, 19850-5437 Less <<
NCT00059722 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - -
NCT02296125 - Active, not recruiting - -
NCT01000740 Non-small Cell Lung Cancer Phase 4 Completed - China, Beijing ... More >> Research Site Beijing, Beijing, China China, Guangdong Research Site Guangzhou, Guangdong, China China, Hubei Research Site Wuhan, Hubei, China China, Jiangsu Research Site Nanjing, Jiangsu, China Research Site Suzhou, Jiangsu, China China, Shandong Research Site Jinan, Shandong, China China, Shanghai Research Site Shanghai, Shanghai, China China, Sichuan Research Site Chengdu, Sichuan, China China, Zhejiang Research Site Hangzhou, Zhejiang, China Less <<
NCT01928160 Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Withdrawn(study not accruing) - -
NCT00173524 - Unknown September 2005 Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan Less <<
NCT02296125 Locally Advanced or Metastatic... More >> EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer Less << Phase 3 Active, not recruiting June 28, 2019 -
NCT02645149 Melanoma Phase 4 Not yet recruiting August 2021 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez    612 9911 7200    maria.gonzalez@melanoma.org.au    Principal Investigator: John Thompson          Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez    +612 9911 7200    maria.gonzalez@melanoma.org.au    Contact: Alex Menzies    +612 9911 7200    info@melanoma.org.au    Sub-Investigator: Georgina Long          Principal Investigator: Alex Menzies Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT01288430 Solid Tumors ... More >>Non-small Cell Lung Carcinoma Less << Phase 1 Terminated - United States, California ... More >> Duarte, California, United States Loma Linda, California, United States Orange, California, United States United States, Florida Orlando, Florida, United States United States, Indiana Indianapolis, Indiana, United States United States, Michigan Detroit, Michigan, United States United States, Oregon Portland, Oregon, United States United States, Texas San Antonio, Texas, United States United States, Washington Seattle, Washington, United States Less <<
NCT02142036 Metastatic Cancer Phase 2 Active, not recruiting January 2022 Norway ... More >> Akershus University Hospital Lillestrøm, Norway, 1478 The Norwegian Radium Hospital Oslo, Norway, 0379 Less <<
NCT02701231 Lung Neoplasms Not Applicable Recruiting December 2020 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Liang-An Chen, MD, phD    8610-55499027    chenla301@263.net    Principal Investigator: Liang-An Chen, MD, phD          China, Shandong Affiliated hospital of Shandong University of traditional Chinese medicine Not yet recruiting Jinan, Shandong, China, 250011 Shandong Provincial Hospital Not yet recruiting Jinan, Shandong, China, 250021 China, Shanxi Xijing Hospital affiliated to the Fourth Military Medical University Not yet recruiting Xi'an, Shanxi, China, 710032 Less <<
NCT02475720 - Completed - Japan ... More >> Izumi Municipal Hospital Izumi, Osaka, Japan, 594-0071 Less <<
NCT02836847 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 2020 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: yingbin liu    13918803900    laoniulyb@163.com Less <<
NCT01256437 Acneiform Rash Phase 2 Completed - Israel ... More >> Davidoff Center, Rabin Medical Center, Beilinson Petach Tikva,, Israel, 49100 Less <<
NCT02208583 Hormone Refractory Prostate Ca... More >>ncer Less << Not Applicable Unknown December 2016 China, Tianjin ... More >> Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Wang HaiTao, Ph.D    +86-18630955984    peterrock2000@126.com    Principal Investigator: Wang HaiTao, Ph.D Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02805530 Carcinoma, Non-Small-Cell Lung... More >> Synchronous Neoplasms Less << Not Applicable Recruiting December 2017 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Mexico, 14080 Contact: Oscar Arrieta    015556280400    ogarrieta@gmail.com Less <<
NCT03053297 - Terminated(Cancelled due to ch... More >>anges in the scientific landscape. Decision was made after thorough evaluation of of pros&cons, ethical as well as regulatory consideration) Less << - -
NCT00898924 - Completed - -
NCT03258671 Non-Small Cell Lung Cancer ... More >> Nonsmall Cell Lung Cancer Carcinoma, Non-Small-Cell Lung Less << Not Applicable Not yet recruiting December 30, 2020 China, Guizhou ... More >> The affiliated hospital of Guizhou medical university Not yet recruiting Guiyang, Guizhou, China, 550004 Contact: Lu Bing, MD    86-18275356814    ouyangww103173@163.com Less <<
NCT03768375 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 30, 2021 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: Yingbin Liu, PHD    13918803900    laoniulyb@163.com    Principal Investigator: yingbin liu, PHD Less <<
NCT02736513 Lung Cancer Phase 2 Recruiting May 2020 Israel ... More >> Rabin Medical Center Recruiting Petach Tikva, Israel, 49100 Contact: Nir Peled, MD PhD FCCP       nirp@clalit.org.il Less <<
NCT01514877 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Completed - China, Zhejiang ... More >> Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 Less <<
NCT02293733 - Completed - France ... More >> Centre Hospitalier D Argenteuil Argenteuil, Val D'oise, France, 95100 Site 12 Aix En Provence, France, 13100 Centre Hospitalier Universitaire Angers, France, 49033 Centre Hospitalier du Morvan Brest, France, 29200 Centre François Baclesse Caen, France, 14000 Centre Hospitalier René Dubos Cergy-pontoise, France, 95301 Site 33 Creteil, France, 94010 Site 07 Draguignan, France, 83300 Site 32 Elbeuf, France, 76503 Site 04 GAP, France, 05000 Centre Hospitalier Les Oudairies La Roche Sur Yon, France, 85000 Hospital du Cluzeau Limoges, France, 87042 Site 00 Limoges, France Centre Hospitalier Régional Longjumeau, France, 91160 Site 25 Mantes La Jolie, France, 78200 Site 06 Marseille, France, 13274 Site 01 Meaux, France, 77108 Site 19 Perigueux, France, 24019 Site 20 Rennes, France, 35033 Site 18 Rouen, France, 76031 Site 17 Rouen, France, 76233 Hôpital Yves Le Foll Saint Brieuc, France, 22023 Site 14 Toulon, France, 83800 Site 11 Villefranche Sur Saone, France, 69655 Less <<
NCT02405247 - Terminated(Team's request.) - United States, California ... More >> Research Site Oceanside, California, United States Research Site Santa Rosa, California, United States Korea, Republic of Research Site Seongnam, Gyeonggido, Korea, Republic of Research Site JinJoo, Gyeongsangnamdo, Korea, Republic of Research Site Ulsan, Ulsan Gwangyeogsi, Korea, Republic of Less <<
NCT03071705 Non-Small Cell Adenocarcinoma ... More >> Tyrosine Kinase Mutation EGFR Gene Mutation Less << Not Applicable Recruiting December 2017 Mexico ... More >> Instituto National de Cancerologia Recruiting Mexico, Mexico, 14080 Contact: Oscar Gerardo MD Arrieta, Oncology    015556280400 ext 71101    ogar@servidor.unam.mx Less <<
NCT01997775 Non-small Cell Lung Cancer Phase 2 Terminated(Difficult enrollmen... More >>t) Less << - Taiwan ... More >> National Cheng-Kung Uni. Hosp. Tainan, Taiwan, 704 Less <<
NCT01967095 EGFR-Mutant Lung Cancer Phase 1 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Rockville Centre Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT02876081 SMALL CELL LUNG CARCINOMA Phase 2 Withdrawn(medical decision) December 2018 France ... More >> Groupe Hospitalier Paris Saint Joseph Paris, Ile-de-France, France, 75014 Less <<
NCT01100840 - Unknown - Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Ross Andrew Soo, MBBS    65 6772 4624    ross_soo@nuhs.edu.sg    Principal Investigator: Ross Andrew Soo, MBBS Less <<
NCT02216916 HNSCC Phase 2 Unknown August 2016 Korea, Republic of ... More >> Yonsei University Recruiting Seoul, Korea, Republic of Contact: Cho Byung Chul    82-10-5212-8867 ext 84320    cbc1971@yuhs.ac Less <<
NCT01098500 - Completed - -
NCT02954523 EGFR Gene Mutation ... More >> Nonsmall Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting November 2021 United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Jeanette Crawford, RN    202-687-0893    crawfojg@georgetown.edu    Contact: Tisdrey Torres, RN    202-687-9861    tt665@georgetown.edu    Principal Investigator: Giuseppe Giaccone, MD PhD          Sub-Investigator: Chul Kim, MD          United States, New Jersey John Theurer Cacner Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Allison Abate    551-996-0233    alison.abate@hackensackmeridian.org    Principal Investigator: Martin Gutierrez, MD Less <<
NCT03491709 Colorectal Cancer Phase 1 Not yet recruiting June 1, 2019 -
NCT01608022 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Completed - Korea, Republic of ... More >> Severance hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01098500 - Completed - -
NCT00015964 Head and Neck Cancer PHASE2 COMPLETED 2025-07-05 University of Chicago Cancer R... More >>esearch Center, Chicago, Illinois, 60637-1470, United States|Louis A. Weiss Memorial Hospital, Chicago, Illinois, 60640, United States|Cancer Care Specialists of Central Illinois, S.C., Decatur, Illinois, 62526, United States|Evanston Northwestern Health Care, Evanston, Illinois, 60201, United States|Ingalls Memorial Hospital, Harvey, Illinois, 60426, United States|Columbia LaGrange Memorial Hospital, LaGrange, Illinois, 60525, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, 61602, United States|Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, 46885-5099, United States|Michiana Hematology/Oncology P.C., South Bend, Indiana, 46617, United States|Oncology Care Associates, P.L.L.C., Saint Joseph, Michigan, 49085, United States Less <<
NCT00265070 Prostate Cancer PHASE2 COMPLETED 2025-08-11 Research Site, Vancouver, Brit... More >>ish Columbia, Canada|Research Site, London, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Montreal, Canada Less <<
NCT00242801 NSCLC PHASE3 COMPLETED 2025-04-05 Research Site, Capital Federal... More >>, Buenos Aires, Argentina|Research Site, Bahia Blanca, Argentina|Research Site, Buenos Aires, Argentina|Research Site, La Plata, Argentina|Research Site, Mar del Plata, Argentina|Research Site, Rosario, Argentina|Research Site, Santa Fe, Argentina|Research Site, Concord, New South Wales, Australia|Research Site, Potts Point, New South Wales, Australia|Research Site, St. Leonards, New South Wales, Australia|Research Site, Chermside, Queensland, Australia|Research Site, South Brisbane, Queensland, Australia|Research Site, Ashford, South Australia, Australia|Research Site, Woodville, South Australia, Australia|Research Site, Melbourne, Victoria, Australia|Research Site, Parkville, Victoria, Australia|Research Site, Prahran, Victoria, Australia|Research Site, Wodonga, Victoria, Australia|Research Site, Woodville South, Australia|Research Site, Fortaleza, CE, Brazil|Research Site, Belo Horizonte, MG, Brazil|Research Site, Rio de Janeiro, RJ, Brazil|Research Site, Porto Alegre, RS, Brazil|Research Site, Sao Paulo, SP, Brazil|Research Site, Sorocaba, SP, Brazil|Research Site, Pleven, Bulgaria|Research Site, Plovdiv, Bulgaria|Research Site, Sofia, Bulgaria|Research Site, Stara zagora, Bulgaria|Research Site, Varna, Bulgaria|Research Site, Veliko Tarnovo, Bulgaria|Research Site, Calgary, Alberta, Canada|Research Site, Edmonton, Alberta, Canada|Research Site, Monoton, New Brunswick, Canada|Research Site, Mississauga, Ontario, Canada|Research Site, Newmarket, Ontario, Canada|Research Site, St. Catherines, Ontario, Canada|Research Site, Sudbury, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, York, Ontario, Canada|Research Site, Laval, Quebec, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Ste-Foy, Quebec, Canada|Research Site, Various Cities, Chile|Research Site, Talinn, Estonia|Research Site, Tartu, Estonia|Research Site, Freiburg, Baden-Wurttemberg, Germany|Research Site, Heidelberg, Baden-Wurttemberg, Germany|Research Site, Muchen, Bayern, Germany|Research Site, Frankfurt, Hessen, Germany|Research Site, Munster, Nordrhein-Westfalen, Germany|Research Site, Bad Segeberg, Schleswig-Holstein, Germany|Research Site, Frankfurt, Germany|Research Site, Freiburg, Germany|Research Site, Gauting, Germany|Research Site, Grobhansdorf, Germany|Research Site, Hamburg, Germany|Research Site, Heidelberg, Germany|Research Site, Hemer, Germany|Research Site, Muchen, Germany|Research Site, Athens, Greece|Research Site, Heraklion, Greece|Research Site, Marousi, Greece|Research Site, Thessaloniki, Greece|Research Site, Budapest, Hungary|Research Site, Debrecen, Hungary|Research Site, Deszk, Hungary|Research Site, Kecskemet, Hungary|Research Site, Mosdos, Hungary|Research Site, Mosonmagyarovar, Hungary|Research Site, Pecs, Hungary|Research Site, Szeged, Hungary|Research Site, Torokbalint, Hungary|Research Site, Ujronafj, Hungary|Research Site, Zalaegerszeg-Pozva, Hungary|Research Site, Zalaegerszeg, Hungary|Research Site, India, India|Research Site, Karnataka, India|Research Site, Kolkata, India|Research Site, Vellore, India|Research Site, Dooradoyle, Limerick, Ireland|Research Site, Beaumont Road, Ireland|Research Site, Cork, Ireland|Research Site, Dublin 7, Ireland|Research Site, Dublin 8, Ireland|Research Site, Elm Park, Ireland|Research Site, Daugavpils, Latvia|Research Site, Liepaja, Latvia|Research Site, Riga, Latvia|Research Site, Kaunas, Lithuania|Research Site, Vilnius, Lithuania|Research Site, Kuala Lumpur, Malaysia|Research Site, Nilai, Malaysia|Research Site, Penang, Malaysia|Research Site, Torreon, Coahuila, Mexico|Research Site, Guadalajara, Jalisco, Mexico|Research Site, Monterrey, Neuvo Leon, Mexico|Research Site, Merida, Yucatan, Mexico|Research Site, Acapulco, Mexico|Research Site, Durango, Mexico|Research Site, Guadalajara, Mexico|Research Site, Leon, Mexico|Research Site, Mexico, Mexico|Research Site, Alkmaar, Netherlands|Research Site, Amsterdam, Netherlands|Research Site, Enschede, Netherlands|Research Site, Groningen, Netherlands|Research Site, Leiden, Netherlands|Research Site, Nieuwegein, Netherlands|Research Site, Rotterdam, Netherlands|Research Site, Alesund, Norway|Research Site, Bergen, Norway|Research Site, Gjettum, Norway|Research Site, Hamar, Norway|Research Site, Haugesund, Norway|Research Site, Kristiansand, Norway|Research Site, Nordbyhagen, Norway|Research Site, Oslo, Norway|Research Site, Skien, Norway|Research Site, Stavanger, Norway|Research Site, Tromso, Norway|Research Site, Trondheim, Norway|Research Site, Various Cities, Peru|Research Site, Manila, Philippines|Research Site, Pasig, Philippines|Research Site, Quezon City, Philippines|Research Site, Gdansk, Poland|Research Site, Katowice, Poland|Research Site, Krakow, Poland|Research Site, Lodz, Poland|Research Site, Poznan, Poland|Research Site, Szczecin, Poland|Research Site, Zabrze, Poland|Research Site, Bucharest, Romania|Research Site, Bucuresti, Romania|Research Site, Cluj Napoca, Romania|Research Site, Craiova, Romania|Research Site, Iasi, Romania|Research Site, Timisoara, Romania|Research Site, Moscow, Russian Federation|Research Site, St. Petersburg, Russian Federation|Research Site, Singapore, Singapore|Research Site, Bratislava, Slovakia|Research Site, Dolny Kubin, Slovakia|Research Site, Jilina, Slovakia|Research Site, Kojice, Slovakia|Research Site, Martin, Slovakia|Research Site, Michalovce, Slovakia|Research Site, Nitra-Zobor, Slovakia|Research Site, Nitra, Slovakia|Research Site, Nove Zamky, Slovakia|Research Site, Poprad - Kvetnica, Slovakia|Research Site, Poprad, Slovakia|Research Site, Prejov, Slovakia|Research Site, Trnava, Slovakia|Research Site, Vasteras, Vastmanlands Lan, Sweden|Research Site, Goteborg, Sweden|Research Site, Huddinge, Sweden|Research Site, Jonkoping, Sweden|Research Site, Karlstad, Sweden|Research Site, Linkoping, Sweden|Research Site, Lund, Sweden|Research Site, Stockholm, Sweden|Research Site, Uppsala, Sweden|Research Site, Pan-Chiao, Taipei, Taiwan|Research Site, Kaohsiung, Taiwan|Research Site, Taichung, Taiwan|Research Site, Tainan, Taiwan|Research Site, Taipei, Taiwan|Research Site, Tao-Yuan, Taiwan|Research Site, Bangkok, Thailand|Research Site, Chiang Mai, Thailand|Research Site, Ankara, Turkey|Research Site, Istanbul, Turkey|Research Site, Izmir, Turkey|Research Site, Various Cities, Ukraine|Research Site, Cambridge, Cambrideshire, United Kingdom|Research Site, Exeter, Devon, United Kingdom|Research Site, Colchester, Essex, United Kingdom|Research Site, Romford, Essex, United Kingdom|Research Site, Gorleston, Great Yarmouth, United Kingdom|Research Site, Fulwood, Lanc, United Kingdom|Research Site, Norwich, Norfolk, United Kingdom|Research Site, Nottingham, Northamptonshire, United Kingdom|Research Site, Belfast, Northern Ireland, United Kingdom|Research Site, Birmingham, West Midlands, United Kingdom|Research Site, Aberdeen, United Kingdom|Research Site, Birmingham, United Kingdom|Research Site, Bradford, United Kingdom|Research Site, Brighton, United Kingdom|Research Site, Coventry, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Essex, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Guildford, United Kingdom|Research Site, Gwynedd, United Kingdom|Research Site, Harrogate, United Kingdom|Research Site, Huddersfield, United Kingdom|Research Site, Hull, United Kingdom|Research Site, Lancaster, United Kingdom|Research Site, Leicester, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Newcastle-upon-Tyne, United Kingdom|Research Site, Nottingham, United Kingdom|Research Site, Oxford, United Kingdom|Research Site, Reading, United Kingdom|Research Site, Southampton, United Kingdom|Research Site, Swansea, United Kingdom|Research Site, Wolverhampton, United Kingdom|Research Site, York, United Kingdom|Research Site, Various Cities, Venezuela Less <<
NCT00637026 Breast Cancer PHASE2 COMPLETED 2025-02-05 -
NCT00787410 Mesothelioma PHASE2 COMPLETED 2025-04-08 -
NCT00635856 Prostate Cancer PHASE2 COMPLETED 2025-02-03 -
NCT00095836 Head and Neck Cancer PHASE2 COMPLETED 2025-03-11 Massachusetts General Hospital... More >> Cancer Center, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States Less <<
NCT01405846 Lung Cancer|Head and Neck Canc... More >>er Less << PHASE2 TERMINATED 2025-06-16 Papworth Hospital NHS Trust, P... More >>apworth Everard, Cambs, CB23 3RE, United Kingdom Less <<
NCT00608868 Non Small Cell Lung Carcinoma PHASE4 COMPLETED 2025-01-09 Research Site, Daegu, Korea, R... More >>epublic of Less <<
NCT00241475 Prostate Cancer PHASE2 COMPLETED 2025-10-05 Research Site, Helsinki, Finla... More >>nd Less <<
NCT00177242 Cancer PHASE2 COMPLETED 2025-12-06 University of Pittsburgh Medic... More >>al Center, Pittsburgh, Pennsylvania, 15232, United States Less <<
NCT00228488 Head and Neck Cancer PHASE2 COMPLETED 2025-12-05 Hong Kong, Hong Kong|Singapore... More >>, Singapore Less <<
NCT00344773 Pulmonary Cancer PHASE2 COMPLETED 2025-12-07 Research Site, Seongnam-Si, Ko... More >>rea, Republic of|Research Site, Seoul, Korea, Republic of Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.24mL

0.45mL

0.22mL

11.19mL

2.24mL

1.12mL

22.38mL

4.48mL

2.24mL

References

 

Historical Records

Categories